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Abstract  
Adipose tissue (AT), through secretion of adipokines, plays a central role in regulating 
metabolism. Adiponectin is one of the most abundant adipokines and is linked with 
several physiological mechanisms such as insulin sensitivity and inflammation. The aim 
of this dissertation was to characterize the effect of stage of lactation and of 
supplementation with conjugated linoleic acids (CLA) on blood adiponectin in dairy 
cows. In addition, adiponectin concentrations in different AT depots and the effect of 
lactational and dietary induced negative energy balance (NEB) on blood and milk 
adiponectin were studied in dairy cows. Adiponectin concentrations of blood were 
studied using serum samples obtained from multiparous (MP) and primiparous (PP) 
cows receiving either CLA or a control fat supplement from d -21 to d 252 relative to 
calving, and serum as well as AT samples [3 subcutaneous (sc):  tail-head, sternum and 
withers and 3 visceral (vc): mesenterial, omental and retroperitoneal] from PP cows 
slaughtered at d 1, 42 and 105 of lactation. Effects of lactational and dietary induced 
NEB on plasma adiponectin were investigated in MP cows from d -21 to d 182 relative 
to calving with feed restriction for 3 weeks beginning at around 100 days of lactation. 
Blood adiponectin was decreased from d 21 ante partum, reached a nadir at calving and 
increased during the post partum period. CLA supplementation reduced circulating 
adiponectin post partum in both MP and PP cows and, as indicated by a surrogate 
marker of insulin sensitivity (RQUICKI) also resulted in decreased insulin sensitivity. 
The decline in blood adiponectin around parturition may result from reduced 
adiponectin protein expression in all fat depots. vcAT contained more adiponectin than 
scAT suggesting a relatively higher impact of vcAT on adiponectin blood 
concentrations. However, retroperitoneal AT had the lowest adiponectin content 
compared to the other fat depots and thus seems to play an unique role in lipid 
mobilization in dairy cows. NEB due to feed restriction about 100 days of lactation 
caused a decline in adiponectin secretion through milk but did not affect its plasma 
concentrations. In conclusion, the major changes in blood adiponectin occurred around 
parturition; dietary CLA supplementation reduced circulating adiponectin. Differing 
amounts of adiponectin per AT depot indicate differential contributions to circulating 
adiponectin. The present dissertation serves as a basis for further studies elucidating the 
role and regulation of adiponectin and other adipokines in various pathophysiological 
conditions in cattle.  
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Abstrakt 
Fettgewebe spielt über die Sekretion von Adipokinen eine zentrale Rolle in der Regulation des 
Stoffwechsels. Adiponektin ist eines der am häufigsten vorkommenden Adipokine und ist mit 
verschiedenen physiologischen Prozessen wie Insulinsensitivität und Entzündungsreaktionen 
verbunden. Ziel der vorliegenden Dissertation war es, die Effekte des Laktationstadiums sowie 
einer Supplementation mit konjugierten Linolsäuren (CLA) auf den Blutspiegel von 
Adiponektin bei Milchkühen zu charakterisieren. Des Weiteren wurde die 
Adiponektinkonzentration in verschiedenen Fettdepots von Milchkühen ermittelt, sowie die 
Effekte von sowohl laktationsbedingter als auch fütterungsinduzierter negativer Energiebilanz 
(NEB) auf die Adiponektinkonzentration im Blut und in der Milch untersucht. Die Bestimmung 
der Adiponektinkonzentration erfolgte im Blut multiparer (MP) und primiparer (PP) Kühe, 
welche entweder mit CLA oder einem Kontrollfett gefüttert wurden im Zeitraum von Tag -21 
bis Tag 252 relativ zur Kalbung. In einem weiteren Versuch wurde Adiponektin in Serum, und 
Fettgewebe [3 subkutane (sc) Depots: Schwanzansatz, Sternum und Widerrist, und 3 viszerale 
(vc) Depots: mesenterial, omental und retroperitoneal] bei PP Kühen gemessen, die an Tag 1, 42 
und 105 während der Laktation geschlachtet wurden. Die Effekte einer laktationsbedingten 
sowie einer fütterungsinduzierten NEB auf die Plasmadiponektinkonzentration wurden in MP 
Kühen zwischen Tag 21 vor der Kalbung bis Tag 185 der Laktation untersucht. Die restriktive 
Fütterung erfolgte über einen Zeitraum von drei Wochen, beginnend an Tag 100 der Laktation. 
Die Adiponektinkonzentration im Blut sank von Tag 21 ante partum, erreichte ihren niedrigsten 
Wert zum Zeitpunkt der Kalbung und stieg im postpartalen Zeitraum wieder an. Die CLA-
Supplementation führte sowohl bei MP als auch bei PP Kühen zu einer Reduktion der 
zirkulierenden Adiponektinkonzentration post partum und weißt zudem über einen Marker für 
Insulinsensitivität (RQUICKI) auf eine verminderte Insulinsensitivität hin. Der Abfall der 
Adiponektinkonzentration im Blut um den Zeitraum der Geburt könnte durch eine verringerte 
Adiponektin-Proteinexpression in den  Fettdepots induziert sein. Das viszerale Fettgewebe 
enthielt mehr Adiponektin als das subkutane Fettgewebe, was einen relativ größeren Einfluss 
der viszeralen Depots auf die Blutadiponektinkonzentration vermuten lässt. Das retroperitoneale 
Fettgewebe wies aber, verglichen mit den anderen Depots, den geringsten Adiponektingehalt 
auf und scheint deswegen eine besondere Rolle in der Lipidmobilisation von Milchkühen zu 
spielen. Die fütterungsbedingte NEB im Zeitraum um Tag 100 der Laktation führte zu einer 
Abnahme der Adiponektinsekretion durch die Milch, beeinflusste jedoch nicht die 
Plasmakonzentrationen. Zusammenfassend zeigte sich, dass die größten Veränderungen der 
Adiponektinblutkonzentration im Zeitraum um die Geburt auftraten und das zirkulierende 
Adiponektin durch die CLA-Supplementation reduziert wurde. Die unterschiedlichen Gehalte 
der einzelnen Fettdepots weisen auf unterschiedliche Beiträge der Gewebe zur zirkulierenden 
Adiponektinkonzentration hin. Die vorliegende Dissertation stellt eine Basis für weiterführende 
Studien dar, um die Rolle und Regulation von Adiponektin sowie anderer Adipokine in 
verschiedenen pathophysiologischen Zuständen von Rindern zu klären.  
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1. Introduction 
Milk production of dairy cows has increased steadily based on a combination of several 
factors such as improved management, better nutrition and intense genetic selection. 
Selection of dairy cows directed towards higher milk production is often associated with 
changes in the pattern of nutrient partitioning (Oltenacu and Broom, 2010), decline in 
immune responses (Hoeben et al., 1997) and reproductive performance (Dobson et al., 
2007) as well as higher incidence of metabolic problems such as milk fever and ketosis 
(Fleischer et al., 2001). Most of the metabolic diseases in dairy cows occur within the 
first 2 wk of lactation (Goff and Horst, 1997) and may cause severe economic loss in 
terms of reduced milk production, impaired fertility, extra-expenses for treatment and 
prevention efforts, and increased culling rates. Special feeding practices might help to 
minimize such economical losses and to achieve better animal health around calving 
and lactation. For this purpose, the diet for early lactating cows should be formulated to 
achieve rapid balancing of energy losses induced by milk secretion, faster adaptation of 
rumen function to the lactation diet, and immunomodulation to enable adequate immune 
functions (Goff and Horst, 1997). Feed supplements such as conjugated linoleic acids 
(CLA) have been demonstrated to exert beneficial effects on the immune system in 
humans (Song et al., 2005) and in animals such as mice (Yamasaki et al., 2003a) and 
pigs (Moraes et al., 2012). Conjugated linoleic acids are also known to inhibit milk fat 
synthesis in dairy cows, thus reducing the energy needed for milk production 
(Baumgard et al., 2000, Peterson et al., 2002). Thus, dietary supplementation with CLA 
might be a strategy to minimize the magnitude and duration of negative energy balance 
(NEB) and to improve immunity in early lactating dairy cows.  
 
1.1. Physiological role of adipose tissue during the transition period and in early 
lactation of dairy cows  
The transition period in dairy cows is defined as the period between 3 wk pre partum 
until 3 wk post partum and is characterized by dramatic changes in the endocrine status 
and energy balance of the animal (Grummer, 1995). Energy balance is the difference 
between energy consumed and energy required (for maintenance, growth, production, 
activity and fetal growth) (Grummer and Rastani, 2003). During the pre calving 
transition period, the nutrient demand is increased to support the final phase of 
conceptus growth and lactogenesis. This is accompanied by a gradual decline in feed 
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intake, with the most dramatic decrease during the final wk before calving (Grummer, 
1995). During the early post partum period, voluntary feed intake is not increasing as 
fast as the energy demand for increased milk production, possibly resulting from 
calving stress and change in nutrient density of the diet. Consequently, dairy cows enter 
a state of NEB. In order to accomplish the increased energy demand during this period, 
the homeorhetic drive necessitates mobilization of body reserves, in particular fat from 
adipose tissue (AT). The rate and extent of AT mobilization depend on several factors 
such as body condition at the time of calving, parity, milk production and composition 
of diet (Komaragiri et al., 1998). Thus, AT plays a central regulatory role during the 
period of increased energy demand such as late pregnancy and early lactation in dairy 
cows.  
1.1.1. Adipose tissue  
Adipose tissue is a highly specialized loose connective tissue composed of adipocytes, 
collagen fibers and other cells summarized as the stromal vascular fraction such as 
preadipocytes, endothelial cells, fibroblasts, immune cells, blood vessels and nerves. 
Over the past one and half decades, numerous studies aimed to understand the role of 
AT in homeostatic and metabolic regulation (Deng and Scherer, 2010, Rajala and 
Scherer, 2003, Rosen and Spiegelman, 2006, Yamauchi et al., 2002). In consequence, 
our perception about AT has changed considerably. In addition to their ability to store 
or mobilize triglycerides, adipocytes synthesize and release a wide variety of bioactive 
molecules collectively termed as adipokines or adipocytokines. Examples of adipokines 
include adiponectin, leptin, resistin, visfatin, apelin, chemerin, omentin. Adipokines 
allow for the communication of AT with other organs of the body such as liver 
(Moschen et al., 2012), heart (Cherian et al., 2012), muscles (Zhou et al., 2007), brain 
(Bartness and Song, 2007), reproductive organs (Mitchell et al., 2005) as well as within 
the AT (Karastergiou and Mohamed-Ali, 2010). Adipose tissue is thus involved in the 
coordination of various biological processes including energy metabolism, 
neuroendocrine, cardiovascular, reproductive and immune functions through its 
secretions via autocrine, paracrine and endocrine mechanisms (Figure 1).  
Mammals have two main types of AT depending on their cellular structure and 
functions i.e. brown AT and white AT. Brown AT is primarily present in newborns and 
hibernating mammals, and is involved in the process of heat generation. White AT is 
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the most abundant form of AT in adults and serves as a regulatory center for energy 
metabolism. Based on its anatomical locations, white AT is broadly classified into 
subcutaneous AT (scAT) and visceral AT (vcAT). 
 
 
 
 
1.1.2. Subcutaneous and visceral AT  
The scAT is located in the hypodermal layer of the skin, whereas the vcAT surrounds 
the inner organs in the abdominal cavity and mediastinum. Deep and superficial layers 
of scAT can be separated by the Fascia superficialis (Wajchenberg et al., 2002). Based 
on its locations, vcAT is divided into three major depots, i.e. mesenterial fat (more 
deeply buried around the intestines), omental fat (surround the intestines superficially), 
and retroperitoneal fat (near the kidneys, at the dorsal side of the abdominal cavity) 
(Wronska and Kmiec, 2012). Different AT depots (scAT and vcAT) display distinct 
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structural and functional properties; these may contribute to their differential role in 
physiological mechanisms (Table 1). The precise mechanism for the functional 
heterogeneity among fat depots is unclear.  
 
Table 1. Differences in functional properties of subcutaneous adipose tissue (scAT) and visceral 
adipose tissue (vcAT) in humans, rats and dairy cows 
 
Reports in *dairy cows, †rats, ‡humans. AMPKα1: Adenosine monophosphate-activated protein kinase-
α1; ATGL, adipose triglyceride lipase; CPT1; carnitine palmitoyltransferase-1; HSL: hormone sensitive 
lipase; IS: insulin sensitivity; PPARα/γ: Peroxisome proliferator-activated receptor-α/γ; RPAT: 
retroperitoneal adipose tissue.  
 
 
 
Characteristics  scAT vs. vcAT  Reference 
     
Responsiveness to caloric restriction   vcAT ˃ scAT  Li et al., 2003‡ 
     
Catecholamine induced lipolysis  vcAT ˃ scAT  Wajchenberg, 2000‡ 
     
Antilipolytic effects of insulin  scAT ˃ vcAT   Wajchenberg, 2000‡ 
     
Insulin stimulated glucose uptake  vcAT ˃ scAT 1.  2. Virtanen et al., 2002‡ 
   3.  4.  
Metabolic activity and mitochondrial 
respiration  
 vcAT ˃ scAT 5.  6. Kraunsoe et al., 2010‡ 
   7.  8.  
Glucocorticoid and androgen receptors   vcAT ˃ scAT  Björntorp, 1995‡, 
Rebuffe-Scrive et al., 
1985
‡
 
     Correlation with IS, diabetes type  II, 
atherosclerosis and metabolic risk 
factors 
 vcAT ˃ scAT  Cefalu et al., 1995‡, Fox 
et al., 2007
‡
, Kissebah, 
1996
‡
 
     
Expression of genes (HSL, ATGL) 
and of proteins   (AMPKα1) related to 
lipolysis  
 RPAT ˃ scAT   Locher et al., 2012*, 
Palou et al., 2009
†
   
     
Expression of fatty-acid oxidation 
related genes (PPARα, CPT1) 
 scAT ˃ RPAT   Palou et al., 2009†  
     
Triglyceride turnover rate  RPAT ˃ scAT    Palou et al., 2009†  
     
Adipocyte size   RP AT ˃ other vc 
(mesenterial, 
omental) and sc AT 
 Akter et al., 2011* 
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1.2. Adipokines 
Biologically active secretions of adipose tissue (adipokines) are diversified in terms of 
their protein structure and functions and are known to act at the local 
(autocrine/paracrine) and/or systemic (endocrine) level. They may be protein hormones 
(e.g. leptin, adiponectin, resistin, visfatin), cytokines (e.g. TNF-α, IL-6), chemokines 
(e.g. monocyte chemoattractant protein-1), proteins of the alternative complement 
system (e.g. adipsin, complement factor B), binding proteins (e.g. retinol binding 
protein), extracellular matrix proteins (e.g. monocyte chemotactic protein-1) or growth 
factors (e.g. nerve growth factor, vascular endothelial growth factor). Metabolic 
dysfunctions may partly result from an imbalance in the expression of pro- (e.g. leptin, 
resistin, TNF-α) and anti-inflammatory (e.g. adiponectin) adipokines; therefore, an 
adequate balance between different adipokines is crucial for determining homeostasis in 
the body (Ouchi et al., 2011). Adiponectin is one of the most important adipokines 
linked with several physiological mechanisms such as insulin sensitivity, immunity, 
reproduction, cardiovascular functions (Figure 2).  
 
 
 
1.2.1. Adiponectin and adiponectin receptors  
Adiponectin was independently characterized in the mid 1990s by four different 
research groups using distinct methods and was named as Acrp30 (adipocyte 
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complement-related protein of 30 kDa) (Scherer et al., 1995), apM1 (adipose most 
abundant gene transcript 1) (Maeda et al., 1996), adipoQ (Hu et al., 1996), and GBP28 
(gelatin binding protein of 28 kDa) (Nakano et al., 1996). Adiponectin is a protein 
hormone expressed by differentiated adipocytes with circulating concentrations in the 
µg/mL range, thus accounting for approximately 0.01% of the total plasma protein 
(Arita et al., 1999). The adiponectin monomer is a 30 kDa polypeptide of 247 amino 
acids containing a N-terminal signal sequence, a variable domain, a collagen-like 
domain, and a C-terminal globular domain (Figure 3). It shares strong sequence 
homology with type VIII and X collagen and complement component C1q (Scherer et 
al., 1995). Post-translational modifications such as hydroxylation and glycosylation of 
the lysine residues within the collagenous domain are required for full activity of 
adiponectin (Wang et al., 2002). In contrast to several other adipokines, the plasma 
concentration of adiponectin is markedly reduced in visceral obesity (Goldstein and 
Scalia, 2004).  
Adiponectin secretion from adipocytes is regulated by the endoplasmic reticulum (ER) 
proteins ERp44 and Ero1-Lalpha. Formation of the covalent bond between ERp44 and 
the thiol group of Cys39 on adiponectin molecule allows for the intracellular retention 
of adiponectin (thiol-mediated retention) while the disulfide bond formed between 
ERp44 and Ero1-L alpha releases adiponectin from ERp44 and allows its secretion from 
the adipocytes (Wang et al., 2007). Adiponectin is secreted from adipocytes as full-
length adiponectin in three major isoforms i.e. low molecular weight (LMW), medium 
molecular weight (MMW) and high molecular weight (HMW) isoform (Figure 3) (Waki 
et al., 2003). The half life of MMW and HMW in mice is 4.5 and 9 h, respectively; 
neither MMW nor HMW are interconverted in circulation (Pajvani et al., 2003). 
Proteolytic cleavage of adiponectin molecules results in a product containing a globular 
head domain that still remains biologically active (Fruebis et al., 2001). 
Three putative adiponectin receptors are identified so far, these are the adiponectin 
receptor 1 (AdipoR1), adiponectin receptor 2 (AdipoR2) and T-cadherin. Predominant 
expression of AdipoR1 and AdipoR2 has been observed in skeletal muscle and liver, 
respectively (Yamauchi et al., 2003). Adiponectin receptors have different affinities to 
the various adiponectin isoforms: AdipoR1 is a receptor for globular and full-length 
adiponectin isoforms whereas AdipoR2 has a higher affinity for full-length adiponectin 
isoforms than globular adiponectin (Kadowaki et al., 2006). Moreover, T-cadherin has 
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been identified as a receptor for the MMW and HMW adiponectin but not for the LMW 
or globular forms (Hug et al., 2004). 
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1.2.2. Adiponectin, insulin sensitivity and nutrient partitioning  
Decreased insulin sensitivity (IS) is the situation in which normal insulin concentrations 
produce less biological response than expected. This might be due to changes in the 
sensitivity (the amount of hormones required for a desired response) and/or 
responsiveness (the maximal response to the hormone) of body tissues for insulin 
(Kahn, 1978). Early lactation in high yielding dairy cows is characterized by decreased 
IS in body tissues such as AT and muscle, thereby promoting mobilization of non-
esterified fatty acids (NEFA), amino acids and sparing of glucose for increased nutrient 
demand of mammary gland for milk production (Bell, 1995).  
The role of adiponectin as an insulin sensitizing adipokine was first identified in mice 
by three independent groups (Berg et al., 2001, Fruebis et al., 2001, Yamauchi et al., 
2001). Plasma adiponectin decreases with the decrease of IS in rhesus monkeys (Hotta 
et al., 2001), in mice and in humans (Maeda et al., 2001). Moreover, positive 
associations of plasma adiponectin concentration with IS and inverse relationships with 
several components related to decline in IS, such as serum high-density lipoprotein 
cholesterol, triglycerides and diastolic blood pressure are observed in humans 
(Fernandez-Real et al., 2003, Matsubara et al., 2002). Adiponectin is known to stimulate 
glucose uptake and fatty acid oxidation by myocytes as well as to decrease 
gluconeogenesis in the liver thereby decreasing blood glucose concentrations 
(Yamauchi et al., 2002). The insulin sensitizing effect of adiponectin is mainly through 
inhibition of hepatic glucose production and increased fatty acid oxidation (Lihn et al., 
2005). The metabolic and insulin sensitizing effects of adiponectin have not been fully 
explored in dairy cows.  
Adiponectin inhibits lipolysis in humans and in mice (Qiao et al., 2011, Wedellova et 
al., 2011); therefore, lowered adiponectin concentrations facilitate the rate of lipolysis. 
The impact of adiponectin on IS and on metabolism of glucose and fatty acid 
contributes to nutrient partioning and thus may affect the nutrient availability in the 
mammary gland for milk production (Figure 4). Certain pathological conditions such as 
inflammation and endocrine hormones may affect the expression of adiponectin in AT. 
The regulation of adiponectin expression through other hormones and cytokines are 
summarized in Table 2.  
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Table 2. Influences of hormones and cytokines on adiponectin mRNA or protein expression in 
adipose tissue 
 
Hormone/cytokine Cell type Effect  Reference  
    
Insulin  epididymal primary 
adipocytes  
 
↑ protein Cong et al., 2007† 
 omental adipocytes ↑ protein Motoshima et al., 
2002‡ 
 3T3L1 cells ↓ mRNA Fasshauer et al., 
2002 
 perirenal and epididymal 
adipocytes 
↓ mRNA Sun et al., 2009* 
    
Glucocorticoids sc adipocytes ↓ protein Degawa-Yamauchi 
et al., 2005‡ 
 3T3L1 cells ↓ mRNA Fasshauer et al., 
2002 
    
Prolactin sc abdominal 
adipocytes 
↓ mRNA, protein Nilsson et al., 2005‡ 
    
Growth hormone sc abdominal adipocytes ↓ mRNA, protein Nilsson et al., 2005‡ 
    
Testosterone  SGBS adipocytes NE mRNA, protein Horenburg et al., 
2008‡ 
 3T3L1 cells  ↓ mRNA, protein Nishizawa et al., 
2002# Li et al., 2011# 
    
Progesterone  inguinal adipocytes ↓ mRNA (female) 
NE (male) 
Stelmanska et al., 
2012# 
Estradiol SGBS adipocytes NE mRNA, protein Horenburg et al., 
2008‡ 
    
DHE  omental adipocytes  ↑ mRNA Hernandez-Morante 
et al., 2006‡ 
    
TNF-α sc abdominal adipocytes  ↓ mRNA Bruun et al., 2003‡ 
 sc or omental adipocytes ↓ protein Degawa-Yamauchi 
et al., 2005‡ 
 3T3L1 cells ↓ mRNA Fasshauer et al., 
2002; Ruan et al., 
2002 
    
IL-6 sc abdominal adipocytes ↓ mRNA Bruun et al., 2003‡ 
    
C- reactive protein 3T3L1 cells ↓ mRNA Yuan et al., 2007 
    
Reports in *dairy cows, #mice, †rats, ‡humans; NE: no effect; sc: subcutaneous; DHE: 
dehydroepiandrosterone; TNF-α: tumor necrosis factor-α, IL-6: interleukin-6; SGBS: human preadipocyte 
cell line.  
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1.3. Conjugated linoleic acids (CLA) 
The term conjugated linoleic acids (CLA) refers to a heterogeneous group of positional 
and geometric isomers of one of the omega-6 fatty acids, i.e. linoleic acid (cis-9, cis-12, 
octadecadienoic acid) (Figure 5). Based on the positioning of the double bond, 28 
isomers of CLA are possible, however, cis-9, trans-11 and trans-10, cis-12 CLA are the 
most common CLA isomers in the commercially available CLA preparations (Banni, 
2002). Cis-9, trans-11 is the major CLA isomer in ruminant fat (~75–90% of total CLA) 
(Bauman et al., 2008). Dairy cows are able to synthesize the cis-9, trans-11 isomer 
endogenously by two different biosynthetic processes: First, as an intermediate product 
of biohydrogenation of linoleic acid by ruminal bacteria i.e. Butyrivibrio fibrisolvens 
(Kepler et al., 1966), and second, by desaturation of trans-11 C18:1 (vaccenic acid), 
another intermediate in the biohydrogenation of unsaturated fatty acids, by the ∆9-
desaturase enzyme in body tissues such as AT and mammary gland (Bauman et al., 
1999). Details about the metabolic functions of CLA and their role in adiponectin 
expression are given in following sub-sections.  
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1.3.1. Effect of CLA on feed intake and energy balance 
The ability of CLA to reduce food and energy intake in mice was suggested in some 
studies (Takahashi et al., 2002, West et al., 1998) but not in others (Ostrowska et al., 
1999, Yamasaki et al., 2003b). It is reported that CLA supplementation increases 
energy expenditure in AKR/J mice (West et al., 2000) and thereby may affect the 
energy balance of the animal. Improvement in feed efficiency after CLA 
supplementation is also reported in pigs (Wiegand et al., 2001) and double-muscled 
Piemontese young bulls (Schiavon et al., 2010) but was not confirmed in cattle using  
Simmental heifers (Schlegel et al., 2012). Conflicting findings on the effects of CLA 
supplementation on dry matter intake and NEB have been reported in many studies on 
dairy cows (Table 3). The variation in the effects of CLA might be due to differences in 
the study design such as amount and type of CLA supplement fed (individual isomer or 
mixture of isomers), beginning and duration of supplementation and physiological 
condition of animals such as age and stage of lactation.  
 
Table 3. Effects of CLA on dry matter intake (DMI) and post partum negative energy balance 
(NEB) in dairy cows 
Variable CLA Effect Reference 
DMI  inhibitory  Moallem et al., 2010; Pappritz et al., 2011; von Soosten 
et al., 2011 
   
 stimulatory  Shingfield et al., 2004 
   
 no effect Perfield et al., 2002; Bernal-Santos et al., 2003; Odens et 
al., 2007; von Soosten et al., 2011 
   
NEB reduce  Shingfield et al., 2004; Odens et al., 2007 
   
 aggravate  Pappritz et al., 2011;  Hötger et al., 2013 
   
 no effect Bernal-Santos et al., 2003; Selberg et al., 2004; Moallem 
et al., 2010 
 
1.3.2. Metabolic functions of CLA 
Conjugated linoleic acids are known to affect body fat and energy metabolism in 
rodents and in humans (Smedman and Vessby, 2001, West et al., 1998). Results of an in 
vitro experiment on 3T3-L1 adipocytes suggest that the trans-10, cis-12 isomer affects 
fat metabolism by reducing lipoprotein lipase (LPL) activity, intracellular triglyceride 
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content and enhance glycerol release into the culture medium (Park et al., 1999). In 
addition, CLA induce apoptosis and increase fatty acid oxidation in 3T3-L1 
preadipocytes (Evans et al., 2000, Evans et al., 2002). The trans-10, cis-12 CLA isomer 
causes a change in body composition through reduction in body fat and increase in lean 
body mass in mice (Park et al., 1997). In cattle, the trans-10, cis-12 CLA decreased 
lipogenesis and expression of genes involved in milk lipid synthesis in the mammary 
gland and depressed the milk fat content (Baumgard et al., 2000, Baumgard et al., 
2002a).  
Lipoprotein lipase is a key enzyme in lipid metabolism. It catalyses the hydrolysis of the 
triacylglcerol component of chylomicrons and very low density lipoproteins, thereby 
providing NEFA for tissue utilization (Mead et al., 2002). Conjugated linoleic acids 
decrease LPL gene expression in mouse AT (Xu et al., 2003) and in the mammary gland 
of dairy cows (Baumgard et al., 2002a). Therefore, the effects of CLA on fat 
metabolism might be mediated through suppression of LPL expression in AT.  
Several studies reported the ability of CLA to increase fatty acid oxidation in liver and 
AT (Evans et al., 2002, Martin et al., 2000, Ohnuki et al., 2001, West et al., 1998). This 
property of CLA might be partly responsible for the hypolipidemic effect of CLA in 
rodents (Sakono et al., 1999). An increased oxidation of [
14
C] oleic acid is observed in 
3T3-L1 preadipocytes treated with trans-10, cis-12 CLA for 6 d (Evans et al., 2002). 
Trans-10, cis-12 CLA increased AT and hepatic carnitine palmitoyltransferase activity, 
a rate-limiting enzyme for β-oxidation, in rats that consumed a diet containing 1% 
trans-10, cis-12 CLA for 6 wk (Martin et al., 2000). Therefore, it seems that trans-10, 
cis-12 is an isomer that contributes to most of the CLA effects on lipid metabolism.  
Supplementation of CLA during early lactation in dairy cows leads to an increase in 
protein accretion and reduction in body mass (fat and protein) mobilization (von 
Soosten et al., 2012). Abomasal infusion of the trans-10, cis-12 CLA in dairy cows had 
no effect on blood variables such as glucose, insulin, NEFA, and leptin, whereas the 
lipolytic response to epinephrine was reduced (Baumgard et al., 2002b). 
Supplementation with a 1:1 mixture of trans-10, cis-12 and cis-9, trans-11 reduced 
endogenous glucose production and decreased the expression of hepatic genes involved 
in this process i.e. cytosolic phosphoenolpyruvate carboxykinase and glucose-6-
phosphatase in dairy cows (Hötger et al., 2013). These results indicate that dietary CLA 
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supplementation might affect metabolic processes in dairy cows and alters the 
expression of hormones linked with the metabolism such as adiponectin.  
 
1.3.3. Role of CLA in adiponectin expression  
Inhibitory effects of CLA on adiponectin expression were observed in mice and in cell 
culture studies (Miller et al., 2008, Perez-Matute et al., 2007, Poirier et al., 2005). 
Treatment of 3T3-L1 cells with trans-10, cis-12 CLA is associated with a decline in 
cellular and secreted adiponectin content and impairment in the assembly of adiponectin 
isoforms (Miller et al., 2008). A recent study in dairy cows suggests that CLA 
supplementation causes a decrease in adiponectin mRNA expression in omental AT at 
105 days of lactation (Saremi, 2013). However, information about the effect of CLA 
supplementation on circulating adiponectin concentrations in dairy cows was lacking. 
Based on the results of rodents and in vitro studies, the proposed mechanisms involved 
in the effect of CLA on adiponectin expression (Perez-Matute et al., 2007, Poirier et al., 
2005) are presented in Figure 6.  
 
 
 
 
 
1.4. Enzyme-linked immunosorbent assay (ELISA) for bovine adiponectin 
Notwithstanding the well-developed knowledge about the biological role of adiponectin 
in humans and in laboratory animals, studies about the adiponectin in cattle have been 
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impeded due to the lack of reliable assays for bovine adiponectin. To overcome this 
shortcoming, an indirect competitive ELISA test was developed in-house for the 
measurement of adiponectin in bovine samples (Mielenz et al., 2013). Based on the 
principle of competition in antigen-antibody binding, the competitive ELISA is one of 
the formats of ELISA that can be used for quantitative measurements of analyte 
concentrations in a variety of samples with high sensitivity. For validating the in-house 
developed ELISA, several validation criteria such as intra-assay (reproducibility) and 
inter-assay (precision) coefficients of variation, spiking recovery, accuracy, specificity, 
sample stability, sensitivity or limit of detection and measuring range were assessed. 
Details of the ELISA validation, the assay protocol and the composition of buffers and 
solutions for the bovine adiponectin ELISA are presented in appendixes A, B and C, 
respectively.  
 
 
1.4.1. Principle of the ELISA for bovine adiponectin  
 
The adiponectin concentration in a sample is measured by recording the interference in 
an expected signal output. The extent of interference is based on the competition among 
sample adiponectin and coating adiponectin for primary antibody binding sites. More 
adiponectin in a sample results in binding of less peroxidase labelled secondary 
antibody in the well after washing and thus the signal obtained is weaker. Therefore, 
signal output is inversely proportional to the adiponectin concentration in the sample. 
The setup of the different components of the bovine adiponectin ELISA and a typical 
standard curve used for the calculation of adiponectin concentrations is presented in 
Figures 7 and 8, respectively. 
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1.5. Objectives 
Adiponectin is one of the most abundant adipokines in circulation; however, 
information about its concentrations in blood and milk of dairy cows during different 
physiological conditions such as the periparturient period and lactation were lacking. In 
addition, potential differences between the different sc and vcAT depots in terms of 
adiponectin protein expression have not yet been assessed in dairy cattle. Furthermore, 
the variation in circulating and milk adiponectin concentrations after dietary CLA 
supplementation, during lactation or dietary induced NEB in ruminant species including 
cattle has not been studied previously. Therefore, the present research study has been 
designed to fill these gaps of knowledge with the following objectives: 
 
1) To characterize adiponectin concentrations in blood and its tissue concentrations 
during different stages of lactation in dairy cattle by the in-house developed 
ELISA,  
2) To evaluate the effect of CLA supplementation on blood and tissue adiponectin 
concentrations, and 
3) To evaluate the effect of lactational and dietary induced negative energy balance 
on blood and milk adiponectin concentrations  
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ABSTRACT  
Decreasing insulin sensitivity (IS) in peripheral tissues allows for partitioning 
nutrients towards the mammary gland. In dairy cows, extensive lipid mobilization and 
continued insulin resistance (IR) are typical for early lactation. Adiponectin, an 
adipokine, promotes IS. Supplementation with conjugated linoleic acids (CLA) in 
rodents and humans reduces fat mass whereby IR and hyperinsulinemia may occur. In 
dairy cows, CLA reduce milk fat, whereas body fat, serum free fatty acids and leptin are 
not affected. We aimed to investigate the effects of CLA supplementation on serum and 
adipose tissue (AT) adiponectin concentrations in dairy cows during the lactation driven 
and parity modulated changes of metabolism. High yielding cows (n=33) were allocated 
on day 1 post partum to either 100 g/day of a CLA mixture or a control fat supplement 
(CON) until day 182 post partum. Blood and subcutaneous (sc) AT (AT) biopsy 
samples were collected until day 252 post partum to measure adiponectin. Serum 
adiponectin decreased from day 21 pre partum reaching a nadir at calving and thereafter 
increased gradually. The distribution of adiponectin molecular weight forms was neither 
affected by time, parity nor treatment. Cows receiving CLA had decreased serum 
adiponectin concentrations whereby primiparous cows responded about 4 weeks earlier 
than multiparous cows. The time course of adiponectin concentrations in sc AT 
(corrected for residual blood) was similar to serum concentrations, without differences 
between CLA and CON. CLA supplementation attenuated the post partum increase of 
circulating adiponectin thus acting towards prolongation of peripartal IR and drain of 
nutrients towards the mammary gland.  
 
1. Introduction 
The progression from pregnancy to lactation is characterized by comprehensive 
metabolic and endocrine changes. Fetal growth, lactogenesis and galactopoiesis require 
the targeted partitioning of nutrients towards the placenta and the mammary gland, a 
process that is accomplished by decreasing insulin sensitivity (IS) in peripheral tissues 
thus attenuating their uptake of glucose, amino acids and fatty acids and facilitating 
lipolysis in adipose tissue (AT) (Block et al., 2001). Considering the amount of nutrient 
output via milk, dairy cows present a biological extreme: in contrast to rodents and 
primates, in which insulin resistance (IR) develops during pregnancy and fades after 
parturition, dairy cows may maintain IR for several weeks and may excessively 
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mobilize body fat (Tamminga et al., 1997). Adipose tissue is a metabolically active 
tissue, communicating with other peripheral tissues and brain through secretion of 
bioactive molecules collectively termed as ‘adipokines’. The circulating leptin 
concentrations reportedly change during pregnancy and around parturition (Block et al., 
2001; Sattar et al., 1998) and are affected by parity in dairy cows (Wathes et al., 2007). 
Parity is considered as an important factor affecting metabolic and hormonal changes, 
since primiparous cows have not reached their adult body size and continue to grow 
during pregnancy and lactation thus showing significant differences in metabolism and 
lipolytic response when compared to later lactations (Theilgaard et al., 2002; Wathes et 
al., 2007).  
Adiponectin is one of the most abundant adipokines in circulation (Hotta et al., 
2001). Unlike other adipokines which increase with excess body fat mass, adiponectin 
is decreased in obese subjects (Kadowaki and Yamauchi, 2005). Adiponectin inhibits 
lipolysis in AT and decreases IR by stimulating fatty acid oxidation and reducing the 
triglyceride content in muscle and liver (Yamauchi et al., 2001). The low adiponectin 
expression in AT after onset of lactation, might contribute to the decrease in IS, which 
improves glucose supply for milk synthesis (Komatsu et al., 2007). Adiponectin is 
synthesized as a 30 kDa monomer and is subsequently assembled to various oligomers 
detectable as low molecular weight trimers, medium molecular weight (MMW) 
hexamers and high molecular weight (HMW) oligomers (Waki et al., 2003). The HMW 
isoform is the biologically active form of adiponectin since it is associated with 
activation of AMP activated protein kinase in muscle (Waki et al., 2003) and 
improvement in IS (Pajvani et al., 2003). Recently, the adiponectin : leptin ratio (ALR) 
was proposed as a more effective and reliable marker of IS (Inoue et al., 2005) and 
metabolic syndrome (Mirza et al., 2001) than adiponectin or leptin alone.  
The term conjugated linoleic acids (CLA) refers to a mixture of positional and 
geometric isomers of octadecadienoic acids, a naturally occurring group of dienoic 
derivatives of linoleic acid. Supplements containing the two main isomers cis-9, trans-
11 and trans-10, cis-12 with a 50:50 ratio have been demonstrated to promote fat loss in 
rodents and obese or overweight humans and also to prevent body fat accumulation in 
mice (Park et al., 2007). Adverse side effects of using CLA mainly concern the 
induction of fatty liver and IR (Poirier et al., 2005; Riserus et al., 2002). In dairy cows, 
CLA supplementation mainly concerns the mammary gland by reducing milk fat 
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synthesis, whereas body fat and lactation induced lipolysis remain unaffected (Pappritz 
et al., 2011). In the present study, we hypothesized that for the homeorhetic adaptations 
to lactation, tissue and circulating adiponectin concentrations will be in support of 
peripartal IR and that the response to CLA will differ depending on stage of lactation 
and parity.  
The objectives of the present study were (I) to characterize circulating 
adiponectin concentrations from late pregnancy to early lactation and then throughout 
lactation in dairy cows, (II) to evaluate potential effects of long term CLA 
supplementation and parity on circulating adiponectin and characterization of its 
molecular weight forms, (III) to compare the adiponectin serum concentration with 
ALR, (IV) to identify changes of the adiponectin concentrations in subcutaneous (sc) 
AT around parturition and early lactation, and (V) to characterize the relationship of 
insulin, IGF-1, nonesterified fatty acids (NEFA) concentrations in blood, body 
condition and systemic IS with adiponectin, leptin and ALR.  
 
2. Materials and Methods 
2.1. Animals and treatments 
This study was conducted at the experimental station of the Friedrich Loeffler 
Institute, Federal Research Institute for Animal Health, Braunschweig, Germany. All 
animal experiments were approved by the Lower Saxony state office for consumer 
protection and food safety (LAVES, file no. 33.11.42502-04-071/07, Oldenburg, 
Germany). The experimental design has been described in detail elsewhere (Pappritz et 
al., 2011). Briefly, pregnant German Holstein Friesian cows either multiparous (MP, 2 
to 4 preceding lactations, n = 22) or primiparous (PP, first pregnancy, n = 11) were 
studied from day (d) 21 pre partum until d 252 post partum. In period 1 (d 21 pre 
partum until the day of calving), all animals were housed in group pens according to 
their feeding group and had free access to water. The diet was a partial mixed ration 
(PMR) consisting of 63% silage and 37% concentrate (6.8 MJ NEL/kg DM) on dry 
matter (DM) basis. The diets were formulated according to the recommendation of the 
Society of Nutrition Physiology ((GfE) Ausschuss für Bedarfsnormen der Gesellschaft 
für Ernährungsphysiologie. Nr. 8. Empfehlungen zur Energie- und Nährstoffversorgung 
der Milchkühe und Aufzuchtrinder; Recommendations of energy and nutrient supply for 
dairy cows and breeding cattle). DLG-Verlag, Frankfurt am Main, Germany, 2001). On 
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d 1 post partum, the animals were randomly allocated to either the control group (CON; 
11 MP cows and 6 PP cows) or the treatment group (CLA; 11 MP cows and 5 PP cows). 
In period 2 (from d 1 until d 182 post partum), the CLA animals received 100 g/d of a 
lipid encapsulated rumen-protected commercial CLA preparation (Lutrell
®
 Pure, BASF 
SE, Ludwigshafen, Germany). The CLA supplement contained 12% each of cis-9, 
trans-11 and trans-10, cis-12 CLA isomers of total fatty acid methyl esters. The animals 
consumed 7.6 g/d each of the trans-10, cis-12 and the cis-9, trans-11 CLA isomer 
(calculated, based on the analyzed proportions in the concentrate). The CON group 
received 100 g/d of a rumen-protected fat preparation (Silafat
®
, BASF SE) in which the 
CLA were substituted by stearic acid. During period 2, each cow of both groups 
received 4 kg/d additional concentrate (8.8 MJ NEL/kg DM) containing the respective 
fat supplement. The detailed composition of the diet and the fatty acid profile of the fat 
supplements are provided elsewhere (Pappritz et al., 2011). To identify potential post 
supplementation effects, the animals were observed for further 12 weeks after the end of 
supplementation period (defined as period 3). The body condition score (BCS) of each 
animal was recorded at the blood sampling times according to a 5-point scale (1 = lean, 
5 = fat) as previously described (Edmonson et al., 1989).  
 
2.2. Blood sample collection, adipose tissue biopsies and preparation of tissue extracts  
Blood samples from all animals were collected from the jugular vein on d -21, -
14, -7, 1, 7, 14, 21, 35, 49, 70, 105, 140, 182, 189, 196, 210, 224, 238 and 252 relative 
to parturition. The plasma (heparin and EDTA) and serum samples were obtained 
following standard procedures and were stored at -80°C. Subcutaneous fat samples were 
obtained by biopsy as described previously (Saremi et al., 2012) from the tail head 
region at d -21, 1, 21, and 105 relative to parturition. Tissue samples were immediately 
snap frozen in liquid nitrogen, and then stored at -80°C. For determining the adiponectin 
concentrations in AT, the samples were homogenized in 2 volumes of homogenization 
buffer, i.e. 10 mM HEPES pH 7.4 with complete
®
 protease inhibitor cocktail (Roche, 
Mannheim, Germany; 1 tablet/10 mL buffer) using a Precellys
® 
24 homogenizer in 2 
mL tubes containing 1.4 mm zirconium oxide beads (Peqlab Biotechnologies GmbH, 
Erlangen, Germany). The homogenates obtained were centrifuged twice (14,000 × g, 10 
min, 4°C) to separate the fat layer. The infranatants beneath were collected (without 
tissue debris) and stored at -80°C.   
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2.3. Adiponectin measurements in serum and adipose tissue 
Serum samples and AT preparations were analyzed for adiponectin in duplicate 
using an in-house developed ELISA as described in detail earlier (Mielenz et al., 2013). 
Assay accuracy was confirmed by linearity and parallelism of diluted serum samples. 
The measuring range (consistent with the linear range) of the assay was 0.07-1.0 ng/mL 
and the limit of detection was 0.03 ng/mL. The intra- and interassay coefficients of 
variation (CVs) were 7 and 9%, respectively.  
Correction for residual blood in the tissue extracts was done by comparing the 
transferrin (Tr) content of the tissue preparation to the Tr content of serum. Transferrin 
concentrations in each tissue preparation and the corresponding serum sample were 
determined by an ELISA specific for bovine Tr according to the manufacturer’s 
directions (Bethyl Laboratories Inc., Montgomery, TX) with minor modifications. 
Briefly, microtiter plates (EIA plate 9018; Corning Costar, Cambridge, MA) were 
coated for 1 hour at 25°C with 1:100 diluted affinity purified anti-bovine transferrin 
antibody in carbonate buffer pH 9.6. Tris buffered saline (50 mM Tris, 0.14 M NaCl pH 
8.0) with 0.05% Tween-20
®   
was used for blocking (200 µL/well, 30 min, 25°C) and as 
a sample dilution buffer. After each incubation step, the plates were washed five times. 
Reference serum (250–3.9 ng/mL) and diluted samples were then applied in duplicate 
(100 µL/well). After 1 hour incubation at 25°C, 100 µL of 1: 50,000 diluted HRP 
detection antibodies were added to each well and incubated for 1 further hour. 
Subsequently, substrate solution (0.05 M citric acid, 0.055 M Na2HPO4, 0.05 M urea 
hydrogen peroxide, 0.02 % ProClin
®
 150 and 0.025% of tetramethylbenzidine) was 
added (150 µL/well) and incubated for 15 min at 25°C in the dark. The reaction was 
stopped with 50 µL 1 M oxalic acid, and the OD was determined at 450/630 nm with a 
microtiter plate reader (ELX800, BioTek Instruments Inc., Winooski, VT). The Tr 
concentrations in the AT preparation and in serum were calculated using the Gen5 2.0 
software (BioTek). Accuracy was confirmed by linearity of diluted tissue extract and 
serum samples. The intra- and interassay CVs were 3.7 and 7.8%, respectively. Samples 
with Tr concentrations < 20 ng/mL were re-analyzed at lower dilution. For calculating 
the extent of tissue blood content, we used a normalization factor that was established as 
follows: the AT preparations were scored according to their visible hemoglobin content 
in 5 classes (0 to 5; 0 was for colorless samples and 5 for deep redish samples). The Tr 
content of all samples from class 0 was averaged and the mean value obtained was 
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considered as threshold (0.03 ± 0.00; n = 5), i.e. only values above this threshold were 
considered as being indicative for significant AT blood content. The normalization 
factor was then calculated by forming the ratio between the mean Tr values of all 
samples and the threshold value (0.10 / 0.03 = 3.3). Subsequently, the Tr concentration 
in each individual sample was divided by the normalization factor to obtain the actual 
Tr coming from the blood (normalized Tr concentration in tissue preparations). Further 
calculations for correction for residual blood were done as described elsewhere (de Boer 
et al., 2005). Briefly, the ratio of the Tr concentration in the AT preparation and in the 
corresponding serum sample was calculated; the amount of adiponectin attributable to 
tissue blood content was calculated by multiplying serum adiponectin (µg/mL) with this 
ratio and the resulting product was then subtracted from the total adiponectin measured 
in the AT preparation. Samples showing negative values after calculation for correction 
for residual blood were handled as missing values, since blood adiponectin 
concentrations were exceeding those in the tissue. The concentration of total protein in 
the AT preparations was determined by the Bradford assay (Roti-Nanoquant, Carl Roth 
GmbH, Karlsruhe, Germany). The blood-corrected adiponectin concentrations of the 
tissue preparations (ng/mL) were normalized and are presented as ng adiponectin/mg 
total protein and ng adiponectin/g wet tissue to take potential changes in tissue protein 
content into account. 
To characterize the molecular weight forms of circulating adiponectin, serum 
samples from d 1 and d 105 of lactation (each from PP and MP cows of CON and CLA 
group) were exemplarily examined by Western blot analysis under nonreducing, 
nonheat-denaturing conditions. All samples were diluted with ultrapure water to achieve 
an approximately equal concentration of adiponectin according to preceding ELISA 
analysis (0.75 ng adiponectin/lane). The diluted samples were mixed with sample buffer 
(final concentration: 0.064 M Tris HCl pH 6.8, 1% SDS, 0.01% bromophenol blue, 10% 
glycerol). Before loading on 8% SDS gels, samples were centrifuged for 5 min at 
10,000 × g, 4°C. Proteins separated by SDS-PAGE were transferred onto a 
polyvinylidene diflouride membrane (PVDF) (GE Healthcare Europe, Freiburg, 
Germany) using tank blotting with the Criterion Blotter System (Bio-Rad Laboratories, 
Munich, Germany). After 5 min of incubation in 15% acetic acid, 10% ethanol and 
further washing with 50% methanol (2 × 1 min), the membranes were dried for 3 min at 
60°C. The first antibody, same as in the ELISA (Mielenz et al., 2013), was used (0.25 
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µg/mL) and incubated for 30 min under shaking. After washing (3 × 5 min), a 
1:100,000 dilution of the HRP conjugated secondary antibody (goat-anti-rabbit 
antibody; SouthernBiotech, Birmigham, AL) was incubated for further 30 min. After 
washing (3 × 5 min), the immune complex was detected with an enhanced 
chemiluminescence detection system (GE Healthcare) using CL-XPosure film (Thermo 
Scientific, Munich, Germany). The molecular weight of the developed bands was 
assessed by comparing with a prestained molecular weight marker [Protein Marker VI 
(10-245) Applichem, Darmstadt, Germany].  
 
2.4. Other blood variables 
Plasma insulin was analyzed using a commercially available double antibody 
radioimmunoassay (DSL-1600, Diagnostic Systems Laboratories Inc., Webster, TX). 
The intra- and interassay CVs were 6.3% and 8.8%, respectively. Plasma IGF-1 was 
measured by 2-site-immunoradiometric assay (IRMA, DSL-5600 Active IGF-I-IRMA; 
Diagnostic Systems Laboratories Inc.). The intra- and interassay CVs were between 
3.4% and 8.2%, respectively. Serum leptin concentrations were measured by a 
competitive ELISA (Sauerwein et al., 2004) and the intra- and interassay CVs were 
3.8% and 9.3%, respectively. Plasma NEFA and glucose were estimated by enzymatic 
analysis using commercial kits (NEFA HR [2] R1+ R2 Set, Wako Chemicals GmbH, 
Neuss, Germany; Hexokinase Fluid 5 + 1, MTI Diagnostics GmbH, Idstein, Germany) 
and results are described elsewhere (Pappritz et al., 2011).  
The ‘Revised Quantitative Insulin Sensitivity Check Index’ (RQUICKI) 
provides good and linear correlations with estimates of IS such as homeostasis model 
assessment (HOMA) and quantitative insulin sensitivity check index (QUICKI) in 
human populations (Rabasa-Lhoret et al., 2003). It was also suggested as a measure of 
IS in ruminants (Holtenius and Holtenius, 2007). Estimation of RQUICKI was done 
according to Perseghin et al. (Perseghin et al., 2001), i.e. RQUICKI = 1 / [log(Glucose, 
mg/dL) + log(Insulin, µU/mL) + log(NEFA, mmol/L)], in which a low RQUICKI index 
indicates decreased insulin sensitivity. The serum leptin concentrations and mRNA 
abundance of adiponectin in the sc AT biopsies were quantified earlier (Saremi et al., 
2014) and were used to evaluate potential correlations. 
 
2.5. Statistical analyses 
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All statistical analyses were performed using SPSS (version 19.0, SPSS Inc., 
Chicago, IL). Data were tested for normal distribution using the Shapiro-Wilk test. 
Homogeneity of variances was tested using the Levene’s test. The mixed model 
procedure was used each for serum adiponectin concentrations or ALR as a dependent 
variable. Treatment (CON or CLA) and parity (MP or PP) were considered as fixed 
factor, sampling days as repeated effects, and their respective interactions were included 
into the model. The covariance structure autoregressive (first-order autoregressive 
structure with homogenous variances) followed by Bonferroni correction were used for 
serum adiponectin and ALR data. Differences at each time point between CON and 
CLA groups were compared for MP and PP cows by Student’s t-test or Mann-Whitney 
U test. For the tissue adiponectin concentrations, treatment was not significant and thus 
data were merged and compared across times using the Friedman test. Pearson`s 
correlations (2-tailed) were calculated between adiponectin, leptin, ALR and all other 
blood variables; in addition, data of BCS and RQUICKI were also used to calculate 
correlations. All data are presented as arithmetic means ± SEM, significance was 
declared for P-values < 0.05 and a trend was noted when 0.05 ≤ P ≤ 0.10. 
 
3. Results 
3.1. Adiponectin serum concentrations: Time course, parity and CLA effects 
Time dependent changes of serum adiponectin concentrations during the entire 
experimental period for both treatment and parity groups are shown in Figure 1. Serum 
adiponectin decreased from d 21 before calving to parturition, reached a nadir at the 
time of calving in all groups, and increased gradually thereafter (Figure 1). Treatment 
effects with decreased serum adiponectin concentrations in the CLA groups were 
observed in both PP and MP cows. The CLA effect was detected earlier in PP cows (d 
21 post partum) than in MP cows (d 49 post partum) and persisted until d 140 post 
partum in both PP and MP cows (Figure 1). Serum adiponectin concentrations in PP 
cows were 1.4-fold higher at d 21 post partum compared to d 21 pre partum (P < 0.05).  
After the end of the supplementation period no carry-over effect of CLA was 
observed in PP cows, however, the MP cows treated previously with CLA tended to 
lower adiponectin serum concentrations on d 189 (P = 0.051), d 238 (P = 0.054) and d 
252 (P = 0.091) as compared to MP CON cows. Considering the parity effect, serum 
adiponectin concentrations tended to be higher in MP cows than in PP cows of both the 
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CON (1.12-fold) and the CLA (1.15-fold) group (P = 0.055 and P = 0.079, 
respectively). The P values for the different factors and their interaction for serum 
adiponectin during the different experimental periods are summarized in supplemental 
Table 1. 
 
3.2. Adiponectin to Leptin Ratio (ALR) 
The time dependent changes of ALR are shown in Figure 1. No treatment effect 
was observed in the corresponding serum leptin concentrations (provided in 
supplemental Figure 2). Considering the entire experimental period, no CLA effect on 
the ALR of PP cows was observed, whereas CLA-treated MP cows tended to have 
lower ALR (P = 0.071) than CON MP cows. However, when limited to period 2, the 
ALR of the CLA group was about 1.5-times lower compared to the CON group (P < 
0.05) in MP cows. In PP cows, no treatment effect was observed after the end of 
supplementation, whereas MP CON cows had 1.5- and 1.4-times higher ALR values on 
189 and 238 d post partum, respectively (P ˂ 0.05).  
No parity effect on ALR was observed in the CLA cows, whereas in the CON 
group, MP cows had 1.3-fold higher ALR than PP cows (P < 0.05). The P values for 
different factors and their interactions for ALR during different experimental periods 
are provided in supplemental Table 2. 
 
3.3. Molecular weight distribution of serum adiponectin in primiparous and 
multiparous cows treated with or without CLA 
Using SDS-PAGE and Western immunoblotting without reducing and heat-
denaturing, adiponectin was detected as HMW oligomers of approximately 300 kDa 
and smaller medium molecular forms (MMW) as exemplary shown in Figure 2. Based 
on this and other blots, the MW distribution was apparently neither affected by parity 
nor by CLA treatment.  
 
3.4. Adiponectin concentrations in adipose tissue  
The portion of blood derived adiponectin from total adiponectin measured in the 
tissue preparations was 47.3 ± 1.4%. The adiponectin content in the biopsy preparations 
attributable to blood was 1.32 ± 0.08 µg/mL, ranging from 0.19-5.7 µg/mL. The 
corrected adiponectin concentrations measured in sc AT were related both to mg of total 
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protein and to g of wet tissue and are presented in Figure 3 A and B. No treatment or 
parity effect was found on tissue adiponectin concentrations except higher 
concentrations in CLA group than CON group on d 1 (0.7 ± 0.1 vs. 0.3 ± 0.1 μg/g wet 
tissue; P = 0.004) and lower values in PP cows than in MP cows on d 21 pre partum 
(51.7 ± 15.1 vs. 63.0 ± 6.3 ng/mg protein; P = 0.023 and 0.3 ± 0.1vs. 0.7 ± 0.1 μg/g wet 
tissue; P = 0.019). No further parity or treatment effect was found for the tissue 
adiponectin concentration at any other time point.  
 
3.5. Correlations of adiponectin, leptin and ALR with other variables 
  Serum and sc AT adiponectin concentrations were positively correlated both on 
the basis of µg/mg protein basis (r = 0.333; P < 0.001) and a µg/g tissue basis (r = 
0.391; P < 0.001). Neither the tissue adiponectin protein concentrations, nor the serum 
concentrations were correlated with the sc AT adiponectin mRNA abundance.   
Time dependent changes in blood concentration of glucose, NEFA, insulin, 
RQUICKI, leptin, and IGF-1 are shown in supplemental Figure 1 and 2. The 
correlations of serum adiponectin, leptin and ALR with BCS, NEFA, RQUICKI, insulin 
and IGF-1 are presented in Table 1. Irrespective of treatment, serum adiponectin in MP 
and PP animals was positively correlated with RQUICKI [(MP, r = 0.232; P = 0.003) 
(PP, r = 0.135; P = 0.008)] and negatively correlated with BCS [(MP, r = -0.421; P < 
0.001) (PP, r = -0.303; P < 0.001)] and NEFA [(MP, r = -0.255; P < 0.001) (PP, r = -
0.281; P < 0.001)].  
 
4. Discussion 
4.1. Circulating adiponectin and ARL during late pregnancy and throughout lactation 
  For studying the importance of adiponectin for the metabolic adaptation to the 
energetic needs of lactation, dairy cows provide a unique model due to their high milk 
yield, the extent and duration of negative energy balance at the onset of lactation with 
concomitantly maintained IR. Investigations about adiponectin in cattle have been 
impeded by the lack of valid assays; using semiquantitative Western immunoblotting, 
the peripartal changes recently characterized (Giesy et al., 2012; Mielenz et al., 2013) 
were herein confirmed using an ELISA developed for bovine adiponectin (Mielenz et 
al., 2013) and further longitudinal data about the entire lactation period with newly 
established pregnancies were provided. The circulating adiponectin concentrations 
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decreased from d 21 pre partum, reached a nadir at the time of parturition and thereafter 
increased gradually. In humans, plasma adiponectin levels are reportedly lower at the 
immediate post partum period than during pregnancy (Mazaki-Tovi et al., 2007). 
Similarly, blood adiponectin was demonstrated to slightly decline as pregnancy 
advances, reaching lowest concentrations after delivery and one month thereafter (Asai-
Sato et al., 2006). Changes in circulating adiponectin levels during pregnancy and 
lactation can result from alterations in its expression, secretion, and/or clearance. 
Hyperinsulinemic conditions, such as pregnancy, are associated with decreased 
adiponectin receptors (Kadowaki and Yamauchi, 2005), thereby reduced adiponectin 
sensitivity might be compensated by an increase in adiponectin levels (Mazaki-Tovi et 
al., 2007).  
In rodents, adiponectin increases glucose uptake in skeletal muscle and reduces 
hepatic glucose production by suppressing the expression of molecules involved in 
gluconeogenesis (Yamauchi et al., 2002). Similarly in humans, plasma adiponectin is 
negatively associated with both basal- and insulin-suppressed endogenous glucose 
production as well as with insulin-stimulated whole-body glucose uptake (Stefan et al., 
2003). Due to ruminal fermentation of carbohydrates from feed, cows depend almost 
entirely on gluconeogenesis, with propionate from microbial fermentation being the 
main substrate (Aschenbach et al., 2011). Gluconeogenesis is of particular importance 
during lactation to ensure an adequate glucose supply of the mammary gland to 
synthesize lactose, the key osmotic regulator of milk volume (Reynolds et al., 1988). 
Adiponectin suppresses gluconeogenesis (Zhou et al., 2005). Therefore, the reduction in 
adiponectin concentrations around parturition was suggested as a physiological 
mechanism to improve gluconeogenesis and increase glucose supply to the mammary 
gland for milk production (Saremi et al., 2014). In view of the loss of body condition 
(from 3 weeks before calving until 3 weeks thereafter, BCS dropped from 3.5 ± 0.07 
and 3.3 ± 0.06 to 3.1 ± 0.05 and 3.1 ± 0.06 in MP and PP cows, respectively) with high 
rates of lipolysis as indicated by rapidly increasing NEFA concentrations, an increase 
rather than a decrease of adiponectin might have been expected since circulating 
adiponectin is commonly increasing in obese patients after diet induced weight loss 
(Oberhauser et al., 2012). The physiological prioritization of lactation, which is 
particularly emphasized in dairy cows genetically selected for high milk yields, might 
thus uncouple the relation between body fat and adiponectin in favor of maintaining IR. 
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In addition, a shift in the ratio between visceral and subcutaneous fat depots towards 
more visceral fat might play a role, since circulating adipokine levels are decreasing 
with increasing central adiposity (Arita et al., 1999); however, the portion of the 
different fat depots cannot be adequately quantified in living large animals.  
Late pregnancy, both in humans and animals, is characterized by low-grade 
inflammatory conditions in AT (de Castro et al., 2011; Zhang et al., 2011) with 
increased production of pro-inflammatory cytokines like IL-6 and TNF-α (Radaelli et 
al., 2006). These cytokines and also monocyte chemoattractant protein-1 suppress 
adiponectin synthesis and secretion by adipocytes (Chazenbalk et al., 2010). In addition, 
the hormonal changes related to parturition, i.e. cortisol (Goff and Horst, 1997), 
estradiol-17 β, prolactin (Bell, 1995), insulin (Oda et al., 1989), and growth hormone 
(Bell, 1995; Oda et al., 1989) are likely to affect (together with the aforementioned 
cytokines) the circulating adiponectin concentrations. Adiponectin has recently been 
identified as mediator of the metabolic effects of fibroblast growth factor-21 (FGF21) in 
terms of glucose homeostasis and IS in mice (Lin et al., 2013). However, when 
comparing the pattern of the serum concentrations of FGF21 during the periparturient 
period reported for in dairy cows to the one of the adiponectin concentrations, the peak 
of FGF21 at the day of calving (Schoenberg et al., 2011) coincides with a nadir of 
adiponectin (Giesy et al., 2012; Mielenz et al., 2013 and present study). For the main 
FGF receptors concerned (FGFR1c, FGFR2c) and the co-receptor protein ß-Klotho, the 
mRNA expression in sc AT remained unchanged when comparing 40 d pre partum to d 
7 of lactation (Schoenberg et al., 2011), but corresponding data for the day of parturition 
are not available. It thus remains open whether the phenomenon of low adiponectin 
during high FGF21 concentrations indicates an uncoupling of FGF21 and adiponectin 
during this specific metabolic and hormonal situation, or whether it is a general 
difference related to the species investigated, their sex and their physiological status. 
Serum adiponectin concentrations were affected by parity; MP cows tended to 
have higher adiponectin concentrations than PP cows. Parity may affect blood hormones 
and metabolites, since PP animals are still growing and nutrients are directed both to fetal 
and maternal growth (Coffey et al., 2006). Recently, ALR was suggested as a more 
effective marker for IS (Inoue et al., 2005) and metabolic syndrome (Mirza et al., 2001) 
than adiponectin or leptin alone. In another human study, adiponectin was considered as 
superior to leptin or ALR for identifying metabolic changes (Mojiminiyi et al., 2007). In 
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this study, ALR followed a similar pattern as adiponectin around parturition. Based on 
the higher frequency of significant correlations between adiponectin and insulin, NEFA, 
and RQUICKI, as compared to ALR, we postulate that adiponectin alone is a more 
meaningful marker of metabolic changes around parturition in dairy cows.  
 
4.2. CLA induced changes in circulating adiponectin and ALR 
The transition from late pregnancy to lactation comprises extensive 
physiological and metabolic adaptation to accomplish the nutrient demand for milk 
production. Based on their milk fat reducing effects, CLA have been suggested to 
alleviate the metabolic stress that dairy cows undergo at the onset of lactation by 
decreasing the milk energy output. The milk fat reducing effect was confirmed for the 
animals studied herein (Pappritz et al., 2011). Adiponectin is involved in regulation of 
glucose, fatty acid and energy metabolism (Yamauchi et al., 2001). In the present study, 
we demonstrated that the increase of circulating adiponectin post partum was mitigated 
in PP and MP dairy cows by supplementation with CLA. Contradicting results have 
been published regarding the effect of conjugated linoleic acid (CLA) on adiponectin in 
monogastrics both in vitro and in vivo, whereas ruminant species including cattle have 
not been studied previously. When a mixture of the cis-9, trans-10 and the trans-10, cis-
12 CLA was used as in our present study, decreasing (Poirier et al., 2005) as well as 
increasing (Martins et al., 2010) effects on adiponectin are reported. In addition, a lack 
of CLA effects on circulating adiponectin is documented in human patients (Joseph et 
al., 2011; Norris et al., 2009). In view of the emerging notion that adiponectin is a 
downstream effector of FGF21, recent reports that the trans-10, cis-12 CLA isomer 
induces hepatic expression of FGF21 through PPAR-α in mice (Yu et al., 2012), would 
rather point to an CLA-induced increase of adiponectin. However, the adiponectin 
response to CLA seems complex and probably depends on the basal (patho-) 
physiological condition, in particular body fat portion, the dosage used and the effective 
tissue concentrations of the relevant CLA isomers and the concentration of other 
hormones such as insulin (Perez-Matute et al., 2007).  
Several authors have demonstrated that CLA reduce body fat mass in mice and 
humans (DeLany et al., 1999; Wang and Jones, 2004), mainly through the trans-10, cis-
12 CLA isomer (Wang and Jones, 2004). Hyperinsulinemia triggered by dietary CLA 
was suggested as a reason for decreased adiponectin plasma levels in mice (Poirier et 
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al., 2005). Indeed, the CLA effects on systemic IS in our study resulted mainly from 
increased insulin concentrations whereas NEFA and glucose, the other variables used to 
calculate the RQUICKI, remained largely unchanged. 
After withdrawal of CLA, a trend for a carry-over effect of CLA was observed 
in MP but not in PP cows. However, the metabolic and endocrine characteristics 
recorded herein offer no conclusive explanation for this divergent reaction in animals of 
different parity.   
We investigated the CLA effect on the distribution of circulating adiponectin 
MW forms in PP and MP cows. We observed that adiponectin circulates as HMW and 
MMW oligomers, these molecular weight forms were previously established as the 
primary forms of circulating adiponectin in cattle (Giesy et al., 2012; Raffelsieper et al., 
2012; Suzuki et al., 2007). The exclusive presence of HMW and absence of MMW 
adiponectin isoforms in bovine serum reported recently (Giesy et al., 2012), might be 
due to a different antibody, gel system (6% vs. 8% SDS-PAGE gel) and/or differences 
in the sample preparation and blotting conditions. No CLA or parity effect on the MW 
distribution pattern of circulating adiponectin during d 1 and d 105 of lactation was 
observed. In contrast, results from a study in mice and in adipocyte cell culture suggest 
that using exclusively the trans-10, cis-12 CLA isomer impaired the assembly of MMW 
forms and reduced the cellular as well as the secreted MMW adiponectin levels (Miller 
et al., 2008). 
 
4.3. Adipose tissue adiponectin concentration 
Adiponectin is produced mainly in AT and circulates in blood at high 
concentrations (Maeda et al., 1996). Its secretion is assumed to follow synthesis without 
significant accumulation within the tissue (Hotta et al., 2001). Blood contained in the 
biopsy samples may thus bias the actual tissue concentrations. We therefore used the Tr 
concentration in tissue extracts and serum as a marker for the extent of blood 
contamination in each individual sample. About 20% of total adiponectin concentrations 
measured in the tissue preparation were attributable to blood adiponectin. The variation 
of blood content observed in the tissue samples stresses the importance of correcting 
adiponectin concentrations from AT for the respective blood adiponectin content, at 
least for biopsy samples. However, the correction for residual blood we did might still 
result in negative values (in this study 3 out of 126 samples which were omitted in the 
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statistical analyses). In addition, the consideration of tissue blood content does not allow 
for differentiating the degree of angiogenesis in different AT or different sections within 
a AT depot. Moreover, assessing the MW distribution of adiponectin in tissue 
preparations would be compromised and we thus renounced on doing so.  
The lowest (blood corrected) tissue adiponectin concentrations were observed at 
the time of parturition. This is in agreement with a previous study showing that 
adiponectin secretion from sc AT (expressed as per tissue weight) is reduced in obesity 
and IR in humans (Hoffstedt et al., 2004). In addition, the lowest expression at the time 
around calving was also confirmed in terms of mRNA (Saremi et al., 2014), albeit the 
serum and sc AT adiponectin concentrations were not correlated with adiponectin 
mRNA abundance in sc AT in the current study. No correlation between plasma and 
mRNA was also found in sc AT of mice (Combs et al., 2003), Rhesus monkeys (Hotta 
et al., 2001) and humans (Garaulet et al., 2004). When comparing late pregnant (d 40 
pre partum) versus early lactating cows (d 7 post partum), the decline of adiponectin 
plasma concentrations was not mirrored in adiponectin mRNA abundance which 
remained constant in sc AT (Giesy et al., 2012). Based on the similar time course of 
serum and sc AT adiponectin protein concentrations with the correlation established 
between serum and tissue, sc AT may contribute to declining adiponectin 
concentrations around parturition. However, further studies need to address the 
expression of adiponectin mRNA and protein in different sc and visceral AT depots and 
their relationship with blood adiponectin concentration.  
 
4.4. Correlations of adiponectin, leptin and ALR with measures of body condition, 
blood metabolites and metabolic hormones 
When all animals were considered irrespective of treatment and parity, 
adiponectin was negatively associated with BCS but not with insulin. We observed 
significant inverse associations between circulating adiponectin and plasma NEFA and 
IGF-1 concentrations, which is in agreement with earlier human studies (Lavoie et al., 
2009; Morcov et al., 2012). The ALR was unable to provide any additional information 
through correlations as compared to adiponectin alone, except a negative relationship 
with IGF-1 for the pooled data. 
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5. Conclusions 
In summary, circulating adiponectin concentrations gradually decreased pre 
partum with lowest concentrations at the time of parturition, and increased thereafter. 
Long term dietary CLA supplementation reduced circulating adiponectin concentrations 
in both PP and MP cows. Concerning parity, there was a trend for lower adiponectin 
concentrations in PP than in MP cows. In addition, a carry-over effect of CLA after 
cessation of the supplementation was exclusively observed in MP cows. There was no 
apparent effect of treatment, parity or day of lactation on the molecular weight 
distribution of the protein. The lowest adiponectin concentrations in sc AT were 
observed at the time of parturition and increased during early lactation. No relationship 
between circulating or tissue adiponectin concentrations with adiponectin mRNA 
abundance in sc AT was found. Circulating adiponectin was positively correlated with 
RQUICKI indicating that reduced adiponectin around calving promotes IR and thus 
facilitates nutrient partitioning towards the mammary gland. The precise mechanisms 
that change the circulating adiponectin concentrations around parturition, and whether 
CLA interferes locally with other hormones and cytokines produced by AT, to alter 
expression and secretion of adiponectin remains to be determined. 
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Table 1. Pearson correlation coefficients of adiponectin (µg/mL), leptin (ng/mL) and 
adiponectin :  leptin ratio (ALR) with blood variables [presented for control (CON) and 
conjugated linoleic acid (CLA) groups during period of supplementation i.e. from d 1 to d 182 
of lactation (Period 2) and for pooled data (Period 1 + 2 + 3) of multiparous (MP) and 
primiparous (PP) cows as well as for merged data (irrespective of parity and treatment) 
 
Reported correlations are limited to P ≤ .01; BCS = Body Condition Score; NEFA = Non-esterified 
fatty acids; IGF-1 = Insulin like growth factor-1; RQUICKI = Revised Quantitative Insulin 
Sensitivity Check Index; *P ≤ .01; **P ≤ .001 
 
 
 
 
   Period 2  Pooled (Period 1 + 2 + 3) 
Variable Parity Group Adiponectin Leptin ALR  Adiponectin Leptin ALR 
BCS 
 
 
MP CON -0.408
**
    -0.392
**
  -0.310
**
 
CLA -0.389
**
  -0.396
**
  -0.409
**
 0.373
**
 -0.460
**
 
PP CON -0.440
**
  -0.398
**
  -0.414
**
 0.329
**
 -0.546
**
 
CLA     -0.306
**
  -0.291
*
 
NEFA, 
mmol/L 
 
MP CON -0.394
**
    -0.294
**
   
CLA -0.422
**
    -0.239
**
 -0.189
*
  
PP CON -0.511
**
     0.295
*
  
CLA -0.549
**
  -0.411
*
  -0.276
*
  0.287
*
 
Insulin, 
µU/mL 
 
MP CON 0.335
**
  0.295
*
     
CLA 0.324
**
    0.235
**
 0.275
**
  
PP CON        
CLA        
IGF-1, 
ng/mL 
MP CON       -0.284
**
 
CLA      0.492
**
 -0.326
**
 
PP CON  0.366
*
    0.354
*
 -0.417
**
 
CLA     -0.315
*
  -0.324
**
 
RQUIC
KI 
 
 
MP CON 0.272
*
       
CLA        
PP CON        
CLA 0.485
**
  0.370
*
  0.360
**
  0.355
**
 
Merged data (irrespective of parity and treatment) 
BCS -0.388
**
  -0.305
**
  -0.403
**
 0.212
**
 -0.423
**
 
NEFA, mmol/L -0.326
**
  -0.174
*
  -0.221
**
 -0.133
*
  
Insulin, µU/mL         
IGF-1, ng/mL     -0.208
**
 0.323
**
 -0.360
**
 
RQUICKI 0.244
**
    0.126
*
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Supplemental Table 1. P values for fixed factors and their interactions using linear mixed 
model for serum adiponectin during different experiment periods. 
Period 1 = before parturition (d -21 until parturition), Period 2 = period of supplementation (d 1 
to d 182 of lactation), Period 3 = period after supplementation (d 183 of lactation until end of 
experiment). Pooled = merged data of multiparous and primiparous cows of control and 
treatment groups; MP (multiparous cows), PP (primiparous cows), CON (control group), CLA 
(treatment group), T (Trend), ns (not significant). In period 1, a significant parity effect was 
observed (P = 0.004).   
 
 
 
 
 
 
 
 
 
 
Effects  Factors  Period 2 Period 3 Period 2 + 3 Period 1 + 2 + 3 
Treatment CON Time   <0.001 ns <0.001 <0.001 
Parity  ns T (0.076) ns T (0.055) 
Time × Parity  T (0.057) ns ns ns 
 
CLA Time   <0.001 0.024 <0.001 <0.001 
Parity  0.07 ns ns T (0.079) 
Time × Parity  ns ns ns ns 
 
Parity MP Time <0.001 ns <0.001 <0.001 
Treatment T (0.066) 0.034 0.019 0.022 
Time × 
Treatment 
0.001 ns 0.017 0.023 
 
PP Time <0.001 ns <0.001 <0.001 
Treatment 0.003 ns 0.042 ns 
Time × 
Treatment 
ns ns ns ns 
       
Pooled Time  <0.001 ns <0.001 <0.001 
Treatment  0.002 ns 0.005 0.003 
Parity T (0.064) ns 0.034 0.009 
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Supplemental Table 2. P values for fixed factors and their interactions using linear mixed 
model for serum adiponectin to leptin ratio during different experiment periods.   
Period 1 = before parturition (d -21 until parturition), Period 2 = period of supplementation (d 1 
to d 182 of lactation), Period 3 = period after supplementation (d 183 of lactation until end of 
experiment). Pooled = merged data of multiparous and primiparous cows of control and 
treatment groups; MP (multiparous cows), PP (primiparous cows), CON (control group), CLA 
(treatment group), T (Trend), ns (not significant). In period 1, no parity effect was observed. 
 
 
 
 
 
 
 
Effects   Factors  Period 2 Period 3 Period 2 + 3 Period 1 + 2 + 3 
Treatment CON Time   <0.001 ns <0.001 <0.001 
Parity  ns 0.016 0.01 0.006 
Time × Parity  ns ns ns ns 
 
CLA Time   0.032 ns 0.048 0.004 
Parity  ns ns ns ns 
Time × Parity  ns ns ns ns 
 
Parity MP Time <0.001 ns <0.001 <0.001 
Treatment ns T (0.057) T (0.075) T (0.071) 
Time ×  
Treatment 
0.020 ns T (0.084) ns 
  
PP Time <0.001 0.047 0.001 <0.001 
Treatment 0.011 ns ns ns 
Treatment × 
Time 
ns ns ns ns 
   
Pooled Time  <0.001 ns <0.001 <0.001 
Treatment  T (0.081) ns T (0.086) T (0.084) 
Parity 0.036 0.017 0.005 0.003 
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Figure 1. Serum adiponectin concentrations (means ± SEM) and serum adiponectin leptin ratio (ALR) in 
multiparous (MP) and primiparous (PP) cows receiving 100 g/d of either conjugated linoleic acids (CLA, 
Lutrell
®
 Pure, BASF SE, Ludwigshafen, Germany) or a control fat supplement (CON, Silafat
®
, BASF 
SE) from d 1 to d 182 post partum. The statistical results included in the graph comprise the entire 
experimental period (d -21 to d 252 post partum) considering time and treatment as factors. * indicate 
differences (P < .05) and † indicate trends for comparison between CON and CLA groups at the 
individual time points. A detailed statistical evaluation of the different periods and the effect of parity are 
provided in Tables 1 and 2. CON: straight lines, MP cows (□), n = 11, PP cows (○) n = 6; CLA: dashed 
lines, MP cows (■) n = 11, PP cows (●) n = 5; ns = not significant. P1 = experimental period 1 (d -21 
until calving), P2 = experimental period 2 (d 1 until 182 post partum) during which the CON or CLA 
supplement was fed; this period is also indicated by the dotted vertical lines, P3 = experimental period 3 
(after withdrawal of the supplements, d 183 post partum until end of experiment). 
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Figure 2. Exemplary Western blot of adiponectin multimeric isoforms [high molecular weight 
(HMW) and middle molecular weight (MMW)] under nonreducing, nonheat-denaturing 
conditions with sera from multiparous (MP) or primiparous (PP) cows receiving a control fat 
(CON, Silafat
®
, BASF SE, Ludwigshafen, Germany) or conjugated linoleic acids (CLA, 
Lutrell
®
 Pure, BASF SE) on d 1 and d 105 post partum.  
 
 
Figure 3.  Adiponectin concentrations (means ± SEM) in adipose tissue (A) ng/mg total protein 
and (B) ng/g wet tissue basis corrected for blood-derived adiponectin (n = 33). * or ** indicate 
differences at P < 0.05 or P < 0.001, respectively and † indicates trend (P < 0.1). Data were 
merged for analysis since no treatment or parity effect was observed (with the exception of a 
treatment effect on d 21 for the ng/mg total protein values).  
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Supplemental Figure 1. Circulating concentrations of glucose, NEFA and insulin (means ± 
SEM) in multiparous (MP) and primiparous (PP) cows receiving 100 g/d of either conjugated 
linoleic acids (CLA, Lutrell
®
 Pure, BASF SE, Ludwigshafen, Germany) or a control fat 
supplement (CON, Silafat
®
, BASF SE) from d 1 to d 182 postpartum. The statistical results 
included in the graph comprise the entire experimental period (d -21 to d 252 postpartum) 
considering time, treatment and parity as factors. * indicate differences (P < .05) and † indicate 
trends for comparison between CON and CLA groups at the individual time points. Significant 
parity effect (P < .001) was observed for NEFA with lower values in PP cows. CON: straight 
lines, MP cows (□), n = 11, PP cows (○) n = 6; CLA: dashed lines, MP cows (■) n = 11, PP 
cows (●) n = 5; ns = not significant. P1 = experimental period 1 (from d -21 until calving), P2 = 
experimental period 2 (from d 1 until 182 postpartum) during which the CON or CLA 
supplement was fed; this period is also indicated by the dotted vertical lines, P3 = experimental 
period 3 (after withdrawal of the supplements, d 183 postpartum until end of experiment).  
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Supplemental Figure 2. Revised Quantitative Insulin Sensitivity Check Index (RQUICKI),  
circulating concentrations of leptin and IGF-1 (means ± SEM) in multiparous (MP) and 
primiparous (PP) cows receiving 100 g/d of either conjugated linoleic acids (CLA, Lutrell
®
 
Pure, BASF SE, Ludwigshafen, Germany) or a control fat supplement (CON, Silafat
®
, BASF 
SE) from d 1 to d 182 postpartum. The statistical results included in the graph comprise the 
entire experimental period (d -21 to d 252 postpartum) considering time, treatment and parity as 
factors. * indicate differences (P < .05) and † indicate trends for comparison between CON and 
CLA groups at the individual time points. Significant parity effect (P < .01) was observed for 
RQUICKI and IGF-1 with lower values in MP cows. CON: straight lines, MP cows (□), n = 11, 
PP cows (○) n = 6; CLA: dashed lines, MP cows (■) n = 11, PP cows (●) n = 5; ns = not 
significant. P1 = experimental period 1 (from d -21 until calving), P2 = experimental period 2 
(from d 1 until 182 postpartum) during which the CON or CLA supplement was fed; this period 
is also indicated by the dotted vertical lines, P3 = experimental period 3 (after withdrawal of the 
supplements, d 183 postpartum until end of experiment). 
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ABSTRACT  
Adipose tissue (AT) depots are heterogeneous in terms of morphology and adipocyte 
metabolism. Adiponectin, one of the most abundant adipokines, is known for its insulin 
sensitising effects and its role in glucose and lipid metabolism. Very little is known 
about the presence of adiponectin protein in visceral and subcutaneous AT depots. We 
assessed serum adiponectin and adiponectin protein concentrations and the molecular 
weight forms in visceral (mesenterial, omental and retroperitoneal) and subcutaneous 
(sternum, tail-head and withers) AT of primiparous dairy cows during early lactation. 
Primiparous German Holstein cows (n = 25) were divided into a control (CON) and a 
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conjugated linoleic acid (CLA) group. From day 1 of lactation until slaughter, CLA 
cows were fed 100 g of a CLA supplement/d (about 6% of cis-9, trans-11 and trans-10, 
cis-12 isomers each), whereas the CON cows received 100 g of a fatty acid mixture/d 
instead of CLA. Blood samples from all animals were collected from 3 week before 
calving until slaughter on day 1 (n = 5, CON cows), 42 (n = 5 each of CON and CLA 
cows) and 105 (n = 5 each of CON and CLA cows) of lactation when samples from 
different AT depots were obtained. Adiponectin was measured in serum and tissue by 
ELISA. In all AT depots adiponectin concentrations were lowest on day 1 compared to 
day 42 and day 105, and circulating adiponectin reached a nadir around parturition. 
Retroperitoneal AT had the lowest adiponectin concentrations, however, when taking 
total depot mass into consideration, the portion of circulating adiponectin was higher in 
visceral than subcutaneous AT. Serum adiponectin was positively correlated with 
adiponectin protein concentrations but not with the mRNA abundance in all fat depots. 
The CLA supplementation did not affect adiponectin concentrations in AT depots. 
Furthermore, inverse associations between circulating adiponectin and measures of 
body condition (empty body weight, back fat thickness and visceral AT mass) were 
observed. In all AT depots at each time, adiponectin was present as high (about 300 
kDa) and medium (about 150 kDa) molecular weight complexes similar to that of the 
blood serum. These data suggest differential contribution of AT depots to circulating 
adiponectin.  
Keywords: adipose tissue depots, adiponectin, dairy cow, lactation  
 
1. Introduction 
Adipose tissue (AT) is considered as an active endocrine organ synthesising and 
secreting a series of bioactive molecules collectively termed as adipokines. Adiponectin 
(AdipoQ), one of the most abundant circulating adipokines is primarily expressed by 
adipocytes and exerts mainly insulin sensitising effects [1]. Synthesised as a 30 kDa 
monomer, AdipoQ is assembled to various oligomeric forms via disulfide bonds 
through an amino-terminal cysteine and may occur in circulation as low molecular 
weight (LMW; trimer), medium molecular weight (MMW; hexamer) and high 
molecular weight (HMW; congregated multimers) oligomers [2]. Among all molecular 
weight isoforms, the HMW isoform is considered as the most biologically active, being 
associated with improving insulin sensitivity (IS) [3] and activation of AMP activated 
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protein kinase in muscle [2]. Regulation of adiponectin isoform secretion is regulated at 
the level of AT [3] and the spontaneous inter-conversion of hexamers (MMW) and 
HMW do not occur in circulation [4]. Besides its role in regulation of glucose and lipid 
metabolism, pro- and anti-apoptotic functions of AdipoQ have also been demonstrated 
(reviewed by [5]). Therefore, AdipoQ might affect the rate of apoptosis also in AT 
through autocrine or paracrine mechanisms.   
The AT from different anatomical locations differ in fatty acid metabolism [6]. 
Visceral AT (vcAT) mass is more strongly correlated with IS [7], increased risk for 
developing diabetes II and atherosclerosis [8], than subcutaneous AT (scAT). 
Regardless of weight loss interventions such as caloric restriction, pharmacological 
therapy, or exercise, individuals preferentially lose vcAT mass [9], thus suggesting that 
vc adipocytes have a higher lipolytic capacity. Moreover, in rodents and humans, 
removal of sc fat did not improve IS, supporting the hypothesis that vcAT may be 
metabolically more active [10,11]. Site dependent differences in the functional activities 
of vc (retroperitoneal AT) and sc AT depots have also been shown for dairy cows 
[12,13]. When studying the role of AT in processes of homeorhetic regulation in which 
metabolism of all body tissues is dynamically adapted to support a physiological state, 
such as pregnancy or lactation, the anatomical location of AT requires careful 
consideration. Most mammals undergo a period of negative energy balance during early 
lactation, however, in dairy cows selected for high milk yields both the extent and the 
duration of negative energy balance exceed the ones in other mammalian species [14-
16]. In early lactation, the priority of the mammary gland for glucose uptake is 
accomplished by insulin-independent glucose transporters in the mammary gland 
together with a decrease of IS in other peripheral  tissues [17]. Concomitant with the 
peripartal decrease in IS, the circulating AdipoQ concentrations were recently 
demonstrated to decline using semiquantitative Western immunoblot methods [18,19]. 
Recent human studies suggest that by 24 h after delivery there is a decline in HMW and 
MMW isoforms which correspond with approximately an 80% reduction of serum 
AdipoQ concentrations [20].  
Based on the heterogeneity of the metabolic activity in different AT depots and 
the relationship of AdipoQ with IS and lipolysis, we hypothesised that the expression of 
the AdipoQ protein in sc and vc AT depots will change during early lactation. Dietary 
supplementation with conjugated linoleic acids (CLA) affect lipid metabolism and is 
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known to cause decline in milk fat content in dairy cows [21,22]. Therefore, we aimed 
to assess the AdipoQ protein concentrations and the distribution of its different isomeric 
forms (LMW, MMW, and HMW) in 3 different sc and 3 different vc AT depots at 3 
time points during the first 105 days of lactation in primiparous dairy cows with or 
without CLA supplementation. Assuming that not only the AdipoQ protein expression 
by each individual AT will change but also the mass of the individual depot, we took 
the respective fat masses into consideration to estimate the portion of circulating 
AdipoQ present in different fat depots. In addition, we tested for correlations between 
AT AdipoQ, serum AdipoQ, adipocyte size, adipocyte apoptotic rate, several blood 
metabolites, and hormones including a surrogate marker of IS [Revised Quantitative 
Insulin Sensitivity Check Index (RQUICKI)] and variables characterising body fat such 
as body condition score (BCS), back fat thickness (BFT), live weight and empty body 
weight (EBW).  
  
2. Materials and methods 
2.1. Experimental animals and treatments 
In compliance with the European Union Guidelines concerning the protection of 
experimental animals and with approval by the Lower Saxony State Office for 
Consumer Protection and Food Safety, Oldenburg, Germany (File Number 
33.11.42502-04-071/07), the present experiment was conducted at the experimental 
station of the Institute of Animal Nutrition, Friedrich-Loeffler-Institute, Braunschweig, 
Germany. The experimental design is described in detail elsewhere [23]. In brief, 
primiparous lactating German Holstein-Friesian cows (n = 25) with an average age at 
parturition of 23 ± 0.2 months were included in the study 3 wk before the expected date 
of calving and were slaughtered on d 1, 42 and 105 of lactation. For this purpose, the 
animals were kept in a free-stall barn, with free access to water. Before parturition, all 
cows received a similar diet consisting of 60% corn silage and 40% grass silage on a 
dry matter (DM) basis (6.7 MJ of NEL/kg DM) ad libitum and 2 kg of concentrate/d  
(6.7 MJ of NEL/ kg  DM). During lactation, the partial mixed ration (PMR) fed 
comprised 38% corn silage, 25% grass silage (DM basis, 7.5 MJ of NEL/kg
 
DM) and 
37% PMR-concentrate (13.5 MJ of NEL/ kg DM). In addition, each animal was 
provided with concentrate by a computerized concentrate feeding station (3.5 kg/d
 
on a 
DM basis). Feed ingredients of the concentrates are presented in Table 1.  
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Beginning at the day of calving, the animals were randomly assigned to receive 
either a supplement containing CLA (100 g/d Lutrell
®
 Pure, BASF SE, Ludwigshafen, 
Germany; group CLA, n = 10) or a control (CON) fat supplement in which CLA was 
replaced by stearic acid (Silafat
®
; BASF SE, 100 g/d; group CON, n = 15) until 
experimental slaughter. The supplements were provided with the concentrate; the CLA 
group consumed 6.0 g/d of the trans-10, cis-12 CLA isomer and 5.7 g/d of the cis-9, 
trans-11 CLA isomer (calculated based on the analysed proportion in concentrates) 
[23]. Five animals of the CON group were slaughtered on d 1 and thereafter five 
animals of both groups were slaughtered each at d 42 and d 105 of lactation.  
 
2.2. Blood and tissue sample collection 
Blood samples were collected from the jugular vein on d -21, -14, -7, -3, 1 (n = 
25), 7, 14, 21, 28, 42 (n = 20) and 105 (n = 10) relative to parturition. Serum samples 
were obtained by clotting followed by centrifugation (3000 × g, 10 min, 4°C) and stored 
at -80°C until analysed. Body weight was automatically recorded when leaving the 
milking parlor. Body condition was scored using a scale of 1 to 5 (1 = thin, 5 = obese) 
[24] and BFT was determined by ultrasound immediately before slaughter. After the 
morning milking on the respective slaughter days (d 1, 42 or 105), the animals were 
transported to the experimental slaughter facilities, weighed, stunned with a captive 
bolt, and exsanguinated. Samples from different AT depots were collected, rapidly 
frozen in liquid nitrogen and stored at -80°C until analysed. Body parts were weighed as 
they were dissected from the animal. The EBW comprises of weights of all body parts 
except digesta and content of urinary and gall bladder [23]. Mesenteric, omental and 
retroperitoneal fat depots were dissected and weighed during the slaughter process. 
Subcutaneous fat which include fat from different sites such as sternum, tail-head and 
withers was dissected manually from the skin and body with a knife and weighed.  
 
2.3. Preparation of tissue samples for AdipoQ analysis 
  After thawing the tissue samples on ice, they were homogenised in 2 vol of 
homogenisation buffer [10 mM HEPES pH 7.4 with complete
®
 protease inhibitor 
cocktail (one tablet/10 mL buffer, Roche, Mannheim, Germany)] using the Precellys
® 
24 homogeniser (Peqlab Biotechnologies GmbH, Erlangen, Germany). Homogenates 
were centrifuged twice (14,000 × g, 10 min, 4
°
C) to separate the fat layer. The 
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infranatant (without fat and tissue debris) were collected and stored at -20
°
C until 
analysis.  
2.4. Sample analyses  
Serum samples were analysed for AdipoQ in duplicate using an in-house 
developed ELISA as described in detail earlier [19]. Prior to the AdipoQ measurements 
in tissue preparations, parallelism was established and assay accuracy was determined 
by linearity of serial samples dilutions (Fig. 1). The intra- and inter-assay coefficients of 
variation were 7.0% and 11.0%, respectively. The total protein concentration of the 
tissue preparations was determined using the Bradford Assay [Roti-Nanoquant (K880), 
Carl Roth GmbH, Karlsruhe, Germany]. The AdipoQ concentrations of tissue 
preparations (ng/mL) were normalised to total protein concentration or wet tissue 
weight and are presented as ng AdipoQ/mg total protein or ng AdipoQ/g wet tissue. The 
amount of AdipoQ (µg) present in individual AT depots was estimated by multiplying 
the AdipoQ in each g of tissue with the mass of the respective depot. The values were 
further used to estimate the portion of circulating AdipoQ present in individual AT 
depots.  
To characterise the different molecular weight (MW) forms of AdipoQ in tissue 
preparations in comparison with serum, AT samples from d 1, 42 and 105 of lactation 
were exemplarily examined by Western blot analysis under non reducing, non heat-
denaturing conditions. Based on preceding ELISA results, the samples were diluted 
with ultrapure water to obtain approximately the same amount of AdipoQ in each lane 
(0.75 ng AdipoQ per lane). The diluted samples were mixed with sample buffer (0.064 
M Tris HCl pH 6.8, 1% SDS, 0.01% bromophenol blue, 10% glycerol). Before loading 
on 8% SDS gels, samples were centrifuged for 5 min at 10,000 × g, 4°C. Proteins 
separated by SDS-PAGE were transferred onto a polyvinylidene diflouride membrane 
(PVDF; GE Healthcare Europe, Freiburg, Germany) using tank blotting (Criterion 
Blotter System, Bio-Rad Laboratories, Munich, Germany). After 1 h of blocking the 
membrane in Tris-buffered saline-Tween (TBS-T) + 10% Roti
®
-Block (Carl Roth, 
Karlsruhe, Germany), the first antibody (polyclonal rabbit antiserum generated against 
bovine adiponectin; 0.25 µg/mL), i.e. the same as used in the ELISA [19], was 
incubated for 60 min under shaking at room temperature. After 4 washing steps (5 min 
each), the HRP conjugated secondary antibody (goat-anti-rabbit antibody; 1:100,000, 
Southern Biotech, Birmingham, AL, USA) was incubated for another 60 min at room 
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temperature. Finally, the membrane was again washed (4 × 5 min, TBS-T) and the 
immune complex was then detected with an enhanced chemiluminescence detection 
system (GE Healthcare) using CL-XPosure film (Thermo Scientific, Munich, 
Germany). The MW of the bands obtained were assessed by comparison with the bands 
of the MW marker [Biotinylated Protein Ladder, #7727, Cell Signaling Technology, 
Danvers, MA, USA]. 
As a measure of IS, RQUICKI was calculated according to the following 
equation [25]: RQUICKI = 1 / [log (Glucose, mg/dL) + log (Insulin, µU/mL) + log 
(NEFA, mmol/L)]. The data for body weight, BCS, BFT, AT depot masses, adipocyte 
cell size from 100 adipocytes per section, portion of apoptotic cells, plasma IGF-1, 
plasma NEFA and AdipoQ mRNA abundance in the different fat depots were presented 
earlier [26-29] and were used for the correlation analysis in the present study.  
 
2.5. Statistical analyses 
  The serum and tissue AdipoQ concentrations were not affected by CLA 
supplementation, therefore merged data from both groups were used for statistical 
analyses. Data for all variables were first tested for normal distribution with the 
Kolmogorov-Smirnov test and for homogeneity of variances with the Levene’s test. 
Comparison for serum AdipoQ concentration and RQUICKI between each time points 
was done using mixed model procedure (general linear model). Sampling days was 
considered as repeated effect. The covariance structure autoregressive (first-order 
autoregressive structure with homogenous variances) followed by Bonferroni correction 
was used. Mann-Whitney U test was used to analyse the differences in AT depots for 
AdipoQ concentrations, amount of AdipoQ, portion of circulating AdipoQ present and 
time dependent changes in the mass. Correlation coefficients between variables were 
calculated using Pearson correlation analysis. Backward stepwise multivariate linear 
regression analyses were conducted to identify significant independent predictors of 
serum AdipoQ concentration. The variables which were related to serum AdipoQ (r ≥ 
0.55) were included in the models. Some of the variables such as AT AdipoQ 
concentration and tissue mass were highly correlated to each other therefore, to avoid 
multicollinearity, they were entered separately into regression models. Serum AdipoQ 
was regarded as dependent variable and AT measures such as tissue AdipoQ 
concentration, adipocyte cell size, AT depot mass as well as total body fat mass were 
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analysed as independent variables. For correlation and regression analyses the variables 
were log transformed, wherever necessary, to satisfy the statistical assumptions of 
normal distribution for these tests. All statistical analyses were carried out using SPSS 
for Windows version 19.0 (SPSS Inc., Chicago, IL, USA). Data are expressed as means 
± S.E.M., P-values < 0.05 were considered significant and a trend was defined at P ≤ 
0.10. 
 
3. Results 
3.1. Serum AdipoQ and RQUICKI profiles from late pregnancy to early lactation 
The time dependent changes in serum AdipoQ concentrations and RQUICKI are 
shown in Fig. 2. Neither serum AdipoQ concentrations nor RQUICKI were affected by 
CLA supplementation (P > 0.01). The serum AdipoQ concentrations decreased from d 
21 pre partum, reaching a nadir at 3 d pre partum (23% lower concentration compared 
to d 21 pre partum). Thereafter, the concentration increased by about 2-fold until d 14 
postpartum (P < 0.001) and then remained unchanged. The RQUICKI values decreased 
from d 7 pre partum and reached the lowest level at the time of parturition (about 24% 
lower than d 7). After calving RQUICKI values gradually increased and reached pre 
partum levels within the first wk of lactation.  
 
3.2. Tissue AdipoQ concentrations 
  Being not affected by CLA supplementation (P > 0.01), the tissue AdipoQ 
concentrations (ng/mg protein and ng/g wet tissue) in sc and vcAT depots are presented 
in Fig. 3 irrespective of the treatment. Tissue AdipoQ concentrations in all AT depots 
were lowest on d 1 compared to d 42 and d 105. Retroperitoneal AT had about 1.6-fold 
lower AdipoQ concentrations than the mesenterial, omental, tail-head and withers fat 
depots (P < 0.01). When normalised to wet tissue weights, lowest AdipoQ 
concentrations were observed in retroperitoneal AT compared to all other fat depots at 
all time points.  
 
3.3. Total amount of AdipoQ in AT depots 
The total amount of AdipoQ (µg) contained in each individual fat depot was 
calculated using the respective depot concentration and the depot mass during different 
days of lactation and is presented as Fig. 4 A. The corresponding change in fat mass 
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(kg) is provided in Fig. 4 B. Significant declines in fat depot mass on d 42 and d 105 
compared to d 1 were limited to omental and retroperitoneal AT, whereas the depot 
mass of mesenterial and sc AT remained unchanged (Fig. 4 B). Concentrations of 
AdipoQ were lowest in retroperitoneal AT, and were accompanied by decreased 
adipocyte size and depot mass during early lactation. However, when changes in depot 
mass were calculated as a portion of total fat mass (%), a significant decline (1.3-fold, P 
< 0.05) was observed only in retroperitoneal AT. With the exception of retroperitoneal 
AT, the amount of AdipoQ in all vc and sc AT depots was significantly lower on d 1 
compared to d 42 and d 105 (Fig. 4 A). In the retroperitoneal depot, the amount of 
AdipoQ on d 1 and d 42 was about 2.5-fold lower compared to d 105 (P < 0.01). 
Omental AT contained the highest and retroperitoneal AT contained the lowest amounts 
of AdipoQ at all time points. Irrespective of time, the AdipoQ amount was highest in 
omental AT (1709 ± 331.6 µg), whereas retroperitoneal AT (488 ± 81.4 µg) had 2.1, 3.5 
and 2.5 fold lower amounts (P < 0.001) than mesenterial, omental and sc AT depots, 
respectively.  
 
3.4. Estimated portion of circulating AdipoQ in individual fat depots 
 The total plasma volume was calculated considering 36.9 mL/kg body weight, 
given for dairy cows of 2 to 5 years of age [30]. Considering this, the amount of 
AdipoQ (µg) in mesenterial, omental, retroperitoneal, and sc AT corresponded to about 
0.19 %, 0.28 %, 0.09 % and 0.21% of the amount of AdipoQ (µg) in circulation, 
respectively. When taking together all vc depots, the portion of AdipoQ contained in the 
vc depots was consistently higher than in the sc depot (7-fold on d 1, P = 0.002; 2.2-fold 
on d 42, P = 0.003 and 3-fold on d 105, P < 0.001) (Fig. 5). The AdipoQ present in all 
fat depots considered in this study (vc and sc AT) comprised 0.78% of the total AdipoQ 
present in the circulation.  
 
3.5. Correlation analyses 
  The relationships of serum AdipoQ concentration with tissue AdipoQ, AT mass, 
total tissue AdipoQ, adipocyte size and AdipoQ mRNA of each fat depot as well as with 
measures of body condition such as total fat mass, BCS, BFT, live and empty body 
weight are presented in Table 2. Relationships of adipocyte size with tissue AdipoQ 
concentration or RQUICKI are presented in Table 3. Correlation coefficients between 
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tissue AdipoQ and plasma concentrations of IGF-1 and NEFA are presented in Table 4. 
The portion of apoptotic cells (%) in sternum AT was positively correlated with tissue 
AdipoQ [ng/mg protein (r = 0.421, P = 0.036) and ng/g tissue (r = 0.400, P = 0.048)]. 
This relationship was not observed in any other fat depot. No significant correlation was 
found between serum AdipoQ and the portion of apoptotic cells in any of the fat depots. 
Among all measures of body condition, only BFT was associated with the AT AdipoQ 
concentration of all depots except sternum (Table 5). An inverse relationship was 
observed between live body weight (kg) with AT AdipoQ concentrations (ng/mg 
protein) in mesenterial AT (r = -0.421, P = 0.036), retroperitoneal AT (r = -0.456, P = 
0.022) and sc AT from withers (r = -0.449, P = 0.024). Significant relationships 
between depot mass (kg) and tissue AdipoQ concentration were limited to 
retroperitoneal AT (r = -0.456, P = 0.022 and r = -0.608, P = 0.001 for ng/mg protein 
and for ng/g tissue, respectively). The tissue AdipoQ concentrations and RQUICKI 
were not correlated, however, RQUICKI was correlated with the amount of AdipoQ in 
retroperitoneal AT (r = 0.411, P = 0.046), but not in other fat depots.  
 
3.6. Multivariate regression analysis 
  Retroperitoneal and tail-head AdipoQ but not the adipocyte sizes were identified 
as independent predictor for the circulating AdipoQ concentrations (Table 6).   
3.7. Molecular weight distribution of AdipoQ in adipose tissue depots 
 Using SDS-PAGE and Western immunoblotting without reducing and heat-
denaturing conditions, AdipoQ in tissue preparations and in serum samples was 
detected as HMW oligomers of approximately 300 kDa and MMW of approximately 
150 kDa as exemplarily shown in Fig. 6 (A, B, C). The molecular weight distribution 
pattern was similar in serum and all AT depots.  
 
4. Discussion 
Adipose tissue and circulating AdipoQ concentrations were measured in this 
study using an in-house developed and validated competitive ELISA. In view of the 
serum concentrations exceeding by far the ones in AT, we estimated the amount of 
residual blood in the tissue samples using the transferrin concentration in the tissue 
preparations and in serum to be able to correct for blood derived adiponectin. However, 
in contrast to AT samples obtained through biopsies, the blood content in AT samples 
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collected after exsanguination at slaughter was negligible i.e. less than 1% vs about 5% 
for biopsy samples (unpublished observation). Serum AdipoQ decreased around 
parturition confirming earlier studies in which semiquantitative Western 
immunoblotting was used [18,19] and our previous results using the aforementioned 
ELISA [19]. The underlying mechanisms for the decline in circulating AdipoQ 
concentrations around parturition are not entirely known. Our present results indicate 
that the concentration of AdipoQ was significantly lower in all fat depots at the time of 
parturition and increased during early lactation irrespective of the anatomical site. 
Therefore, decreasing circulating AdipoQ around parturition may be the collective 
outcome of significant reduction of AdipoQ protein expression in all fat depots. The 
hormonal changes associated with parturition are probably related with the changes in 
circulating AdipoQ as AdipoQ expression and secretion is reportedly suppressed by 
prolactin, growth hormone, glucocorticoids and TNF-α in vitro [31-33]. Secretion of 
blood hormones via colostrum and milk is a convenient means of biological clearance 
from the maternal circulation [34]. The rate of secretion might be affected by the 
integrity of the blood-milk barrier. In dairy cows, the permeability of mammary gland 
tight junctions is increased during late pregnancy [35] and is closed following 
parturition [36]. This might result into higher secretion of blood AdipoQ into the 
colostrum as reported for certain other blood hormones such as progesterone, estrogen 
and prolactin [37] and consequently contribute to the low blood AdipoQ concentrations 
around calving.  
Adiponectin is known for its insulin sensitizing [38] and lipolysis inhibiting 
effects [39]. In rodents, AdipoQ increases glucose uptake and fatty acid oxidation in 
skeletal muscle as well as reduces hepatic gluconeogenesis [40]. Therefore, lower 
AdipoQ concentrations in circulation around parturition might contribute to increased 
lipolysis, increased glucose production in liver and decreased IS of peripheral organs 
and thus help in nutrient availability to the mammary gland for enhanced milk 
production after calving.  
We observed nearly similar characteristic patterns of the time dependent 
changes in serum AdipoQ concentrations and RQUICKI around parturition and found a 
significant weak positive correlation between these variables during the post-calving 
period suggesting an in vivo effect of AdipoQ on IS. The RQUICKI and adipocyte cell 
size in all fat depots were negatively correlated and this points to adipocyte size as an 
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important determinant of whole body IS. This is in line with earlier in vitro studies 
suggesting that AT of obese subjects, with enlarged cells, is less insulin responsive [41] 
and that stimulation with insulin increases the amount of glucose transporter (GLUT4) 
in the plasma membrane of small fat cells but not of large fat cells [42]. 
Certain fatty acids such as linoleic acid, palmitic acid and eicosapentaenoic acid 
are known to reduce AdipoQ gene expression in 3T3-L1 adipocytes [43]. In addition, 
inhibitory effects of CLA on AdipoQ expression has been observed in mice and in cell 
culture studies [44,45]. In the present study, no effect of dietary CLA supplementation 
on AT or circulating AdipoQ concentrations was observed. Based on the determination 
of fat content and the fatty acid composition of different fat depots in the same animals, 
the transfer of supplemented CLA isomers into the AT depots was only marginal [46]. 
Therefore, we assume that the absence of CLA effects on tissue and circulating AdipoQ 
might be due to the insufficient dose of supplemented CLA to these animals.  
Rate of synthesis, secretion and clearance are the main determinants for 
circulating concentrations of metabolites and hormones. Adiponectin has relatively long 
half life (2.5 to 9 h) and is dependent on its molecular weight form with greater half life 
of HMW isomer compared to the MMW isomer (9 vs 4.5 h) [4,47]. Between different 
AT depots AdipoQ secretion vary substantially [48]. After treatment with the insulin 
sensitizer thiazolidinedione, Motoshima et al. [48] showed that increased circulating 
AdipoQ levels derived from the omental rather than the scAT depot. Moreover, rate of 
AdipoQ secretion by adipocytes from scAT seems to play only a minor role in variation 
of its blood concentration [47]. Thus, the secretion rate alone may not provide an 
optimal estimate of circulating AdipoQ concentrations. The variables such as tissue 
AdipoQ concentration and the changes in the mass of fat depots during the period of 
energy demand such as early lactation may thus give an idea about relative competence 
of AT depots for the variation in circulating AdipoQ concentrations.   
Studies on AT in dairy cows are mainly limited to sc fat, since the vc fat depots 
in the alive animal can neither be quantified due to the lack of appropriate methods for 
large animals such as magnetic resonance imaging, nor routinely be biopsied for tissue 
analyses. Therefore data about metabolic and endocrine differences between vc and sc 
AT depots are largely lacking. To determine the predominant site of AdipoQ secretion, 
we measured the AdipoQ concentration in various fat depots at different periods of 
lactation and further analysed their relationship with serum AdipoQ concentrations and 
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with measures of AT depot and body condition. Retroperitoneal AT had both the lowest 
AdipoQ concentration and the lowest total amount of AdipoQ. In addition, when 
calculated as a proportion of EBW (%), a decline is observed only in retroperitoneal AT 
in the same animals [23]. Therefore, the retroperitoneal AT seems unique as compared 
to the other fat depot in lipid mobilisation during early lactation. In vitro studies on 
human and mouse adipocytes suggest an inhibitory effect of AdipoQ on lipolysis 
[39,49], therefore, the lower concentration of AdipoQ in retroperitoneal AT might 
contribute to the higher lipolytic rate in this depot. The physiological significance of 
depot specific variations in lipolysis is unknown, however, it has been reported that in 
contrast to the retroperitoneal AT, which drains into the systemic circulation, other 
vcAT depots release free fatty acids (FFA) directly to the liver via the portal vein [50]. 
Increased delivery of FFA to the liver impairs the ability of insulin to suppress hepatic 
gluconeogenesis; in addition, increased systemic FFA concentrations from 
retroperitoneal AT may inhibit insulin mediated glucose uptake in skeletal muscle [51]. 
Therefore, a higher rate of lipolysis in retroperitoneal and/or other vcAT depots might 
have positive effects on glucose homeostasis in early lactation by partitioning nutrients 
towards the mammary gland. 
In the current study, serum AdipoQ was negatively correlated with the mass of 
each individual vcAT depot (mesenterial, omental and retroperitoneal AT) as well as 
with the total vcAT mass, however, no relation was observed with scAT mass. In line 
with our findings, studies in humans reported that vcAT is negatively associated with 
circulating AdipoQ, whereas scAT has no significant impact [52,53]. However, this 
relationship might be different in other physiological situations since Frederiksen et al. 
[54] found that scAT rather than vcAT was negatively associated with AdipoQ in 
healthy young men.  
As shown by multiple regression analysis, the amount of AdipoQ in omental 
AT, tail-head AdipoQ concentration, retroperitoneal tissue mass and its AdipoQ 
concentration were observed as significant independent predictors for circulating 
AdipoQ concentration. This is in partial agreement with other studies reporting that 
AdipoQ concentrations are inversely correlated with both vcAT and scAT, however, 
only vcAT was identified as independent determinant of AdipoQ levels [52,55]. 
Therefore, decreased circulating AdipoQ concentrations seems closer related to 
increased vcAT rather than scAT [55].  
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Considering both, the variation in protein expression and change in tissue mass, 
fat depots contribute differently to the circulating concentrations of AdipoQ. Again, the 
importance of the retroperitoneal depot for energy homeostasis through lipolysis during 
the period of high energy demand is supported. 
An inverse relationship of serum AdipoQ concentration with adipocyte size in 
retroperitoneal AT and in sc fat from withers was observed, whereas adipocyte sizes of 
other fat depots were not significantly related. In agreement with these findings, an 
increase in adipocyte sizes was reported to reduce AdipoQ mRNA expression in 
parametrial AT [56]. Adipocyte size is an important determinant for the secretion of 
adipokines and reduced AdipoQ expression in large adipocytes in vivo may be due to 
down regulatory effect of cytokines such as TNF-α, IL-6, or IL-8, being released by 
surrounding cells such as preadipocytes and macrophages [57]. Recently, we reported 
that retroperitoneal adipocyte sizes were mostly larger than the adipocytes from other 
sites, independent of time of lactation [26], therefore, the lower AdipoQ concentration 
in retroperitoneal AT might be due to relatively large size of their adipocytes. 
Adiponectin is known to affect apoptosis both in vivo and in vitro. However, 
controversial reports exist whether AdipoQ might have pro- or anti-apoptotic effects, 
depending on the source and the tissue sensitivity of AdipoQ as well as on the time and 
concentration of the administration [5]. Although the relationship of tissue AdipoQ with 
the number of apoptotic cells (%) was limited to the sternum AT in the present study, 
the positive correlation suggests pro-apoptotic functions of AdipoQ in bovine AT. We 
observed a negative relationship of serum AdipoQ with measures of body condition 
such as live weight, EBW, BCS and BFT which is in concordance with studies in mice 
and in humans suggesting that AdipoQ gene expression and plasma levels are 
significantly reduced in obesity [38]. Abundance of AdipoQ mRNA in different fat 
depots of the same animals are presented earlier [28]. In our study, the AdipoQ mRNA 
abundance was not correlated with serum or tissue AdipoQ concentrations similar to 
earlier studies in humans and animals [58,59]. Factors such as translational regulation, 
post-transcriptional modification and rate of secretion or degradation might be more 
important in regulating circulating AdipoQ concentrations than the gene transcription in 
adipocytes alone. 
Under non reducing and non heat-denaturing conditions, almost all of the 
AdipoQ in AT and serum was present as complexes of hexamers (about 150 kDa), and 
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higher MW forms (about 300 kDa). The HMW and MMW forms were previously 
established as the primary forms of circulating AdipoQ in cattle [60], thus confirming 
the results. The exclusive presence of a HMW form and absence of MMW AdipoQ in 
bovine serum reported recently [18], might be due to a different antibody, gel system 
(6% vs 8% SDS-PAGE gel) and/or differences in sample preparation and blotting 
conditions. For the  AdipoQ isoforms in AT, our results are in partial agreement with 
the finding of Phillips et al. [61], who reported that under non reducing conditions 
almost all of the AdipoQ in human adipocytes is present as complexes consistent with 
higher MW forms, hexamers and trimers. The similar MW distribution pattern of 
AdipoQ in tissue preparation and serum in our study indicate little or no interchange 
between AdipoQ molecular forms in circulation, as reported earlier [62]. 
In summary, we report that fat depots contained different concentrations and 
amounts of AdipoQ during early lactation thus implying differential contribution to the 
circulating AdipoQ concentrations in primiparous dairy cows. In general, vcAT 
contained more AdipoQ than scAT suggesting a higher impact of vcAT to circulating 
concentrations. Decreased circulating AdipoQ concentrations reflect the decline of 
tissue AdipoQ concentrations around parturition which may promote lipolysis and 
energy supply for the milk production in dairy cows. 
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Table 1. Pearson’s correlation coefficient (r) between log serum AdipoQ (µg/mL) and AT 
variables in dairy cows.  
 
AT depot  Variables   log serum AdipoQ 
    r P 
vcAT depot      
Mesenterial AT  log tissue AdipoQ, ng/mg
 
protein  0.541 0.006 
  log total tissue AdipoQ, µg  0.430 0.036 
  Tissue mass, kg  -0.425 0.038 
  Adipocyte size, µm
2
  -0.253 0.232 
  Tissue AdipoQ mRNA  0.275 0.205 
      
Omental AT  log tissue AdipoQ, ng/mg protein  0.661 <0.001 
  log total tissue AdipoQ, µg  0.572 0.003 
  Tissue mass, kg  -0.400 0.053 
  Adipocyte size, µm
2
  -0.278 0.189 
  Tissue AdipoQ mRNA  -0.077 0.726 
      
Retroperitoneal AT  log tissue AdipoQ, ng/mg protein  0.573 0.003 
  log total tissue AdipoQ, µg  0.366 0.079 
  Tissue mass, kg  -0.616 0.001 
  Adipocyte size, µm
2
  -0.551 0.005 
  Tissue AdipoQ mRNA  0.216 0.311 
scAT depot      
Sternum AT  log tissue AdipoQ, ng/mg protein  0.642 0.001 
  Adipocyte size, µm
2
  -0.371 0.074 
  Tissue AdipoQ mRNA  -0.220 0.301 
      
Tail-head AT  log tissue AdipoQ, ng/mg protein  0.635 0.001 
  Adipocyte size, µm
2
  -0.306 0.146 
  Tissue AdipoQ mRNA  0.167 0.446 
      
Withers AT   log tissue AdipoQ, ng/mg protein  0.754 <0.001 
  Adipocyte size, µm
2
  -0.529 0.008 
  Tissue AdipoQ mRNA  -0.124 0.581 
Other body measures       
Total vcAT mass, kg    -0.513 0.010 
Total scAT mass, kg    -0.208 0.328 
Total fat mass, kg 
(vcAT + scAT) 
 
 
  -0.475 0.019 
Live body weight, kg     -0.377 0.069 
EBW, kg    -0.427 0.038 
BCS    -0.361 0.083 
BFT (cm)    -0.550 0.005 
Abbreviations: AT = adipose tissue, vc = visceral, sc = subcutaneous, Total vcAT = mesenterial 
AT + omental AT + retroperitoneal AT, EBW = empty body weight, BCS = body condition 
score, BFT = back fat thickness. Boldface indicates significant associations.   
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Table 2. Relationships (Pearson’s correlation coefficients, r) of adipocyte sizes (µm2)a with log 
tissue AdipoQ concentrations (ng/g tissue) and RQUICKI in dairy cows. 
AT depot log tissue AdipoQ  RQUICKI 
r P  r P 
Adipocyte size (vcAT depot)      
Mesenterial AT -0.166 0.427  -0.442 0.031 
Omental AT -0.421 0.036  -0.423 0.039 
Retroperitoneal AT -0.620 0.001  -0.564 0.004 
      
Adipocyte size (scAT depot)      
Sternum AT -0.343 0.093  -0.621 0.001 
Tail-head AT -0.142 0.499  -0.351 0.093 
Withers AT -0.645 0.001  -0.411 0.046 
Abbreviations: AT = adipose tissue, vc = visceral, sc = subcutaneous, RQUICKI
 
= Revised 
Quantitative Insulin Sensitivity Check Index.
  
a 
Data have been published earlier [26].  
Boldface indicates significant associations.   
 
Table 3. Pearson’s correlation coefficient (r) between log tissue AdipoQ and log plasma IGF-1 
(ng/mL)
a
 and log NEFA (µEq/L)
b
 concentration in dairy cows. 
Abbreviations: AT = adipose tissue, vc = visceral, sc = subcutaneous.  
a
 and 
b
 Data have been published earlier [27] and [23], respectively.  
Boldface indicates significant associations. 
AT depot  Variables  Plasma IGF-1  Plasma NEFA 
    r P  r P 
vcAT         
Mesenterial AT  log tissue AdipoQ, ng/mg protein  0.218 0.295   -0.153 0.467 
  log tissue AdipoQ, ng/g tissue  0.570 0.003  -0.502 0.010 
  log total tissue AdipoQ, µg  0.548 0.005  -0.478 0.016 
         
Omental AT  log tissue AdipoQ, ng/mg protein  0.314 0.126  -0.289 0.161 
  log tissue AdipoQ, ng/g tissue  0.324 0.115  -0.346 0.090 
  log total tissue AdipoQ, µg  0.204 0.328  -0.231 0.266 
         
Retroperitoneal 
AT 
 log tissue AdipoQ, ng/mg protein  0.112 0.593   0.304 0.140 
  log tissue AdipoQ, ng/g tissue  0.413 0.040  -0.524 0.007 
  log total tissue AdipoQ, µg  0.284 0.168  -0.534 0.006 
         
scAT         
Sternum AT  log tissue AdipoQ, ng/mg protein  0.463 0.020  -0.375 0.065 
  log tissue AdipoQ, ng/g tissue  0.472 0.017   0.379 0.062 
         
Tail-head AT  log tissue AdipoQ, ng/mg protein   0.301 0.143  -0.257 0.215 
  log tissue  AdipoQ, ng/g tissue  0.453 0.023  -0.355 0.002 
         
Withers AT   log tissue AdipoQ, ng/mg protein  0.327 0.111  -0.268 0.196 
  log tissue  AdipoQ, ng/g tissue  0.330 0.107  -0.248 0.232 
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Table 4. Pearson’s correlation coefficient (r) between log tissue AdipoQ concentration (ng/g 
tissue) and measures of body condition in dairy cows.   
Abbreviations: AT = adipose tissue, BW = body weight, BFT = back fat thickness, BCS = body 
condition score, EBW = empty body weight. 
a
 Data have been published earlier [23].  
Boldface indicates significant associations. 
 
 
Table 5. Multiple linear regression analyses of the relationship between adipose tissue (AT) 
depot measures with serum AdipoQ concentration. Parameters identified as significant 
independent predictors for serum adiponectin in dairy cows are presented.  
Note: For model 1 AdipoQ concentrations (ng/mg
 
tissue) in each individual AT (mesenterial, 
omental, retroperitoneal, sternum, tail-head, withers AT), whereas for model 2 RP tissue mass 
(kg), RP adipocyte size (µm
2
), wither adipocyte size (µm
2
), log omental total AdipoQ (µg) were 
included due to their strong relationship with serum AdipoQ (r ≥ 0.55).  
 
 
 
 
 
log tissue 
AdipoQ  
 BW (kg)
a
  BFT (cm)
a
  BCS
a
   EBW (kg)
a
 
 r P  r P  r P  r P 
vcAT             
Mesenterial AT  -0.272 0.189  -0.461  0.020  -0.243  0.243  -0.442  0.027 
Omental AT  -0.315 0.125  -0.521  0.008  -0.438  0.029  -0.339  0.098 
Retroperitoneal 
AT 
 -0.357  0.080  -0.508 0.010  -0.295  0.152  -0.391  0.053 
             
scAT             
Sternum AT  -0.214 0.304  -0.204  0.329  -0.103 0.626  -0.276  0.182 
Tail-head AT  -0.175  0.401  -0.527  0.007  -0.366  0.072  -0.319  0.121 
Withers AT  -0.521  0.008  -0.443  0.027  -0.316  0.124  -0.502  0.010 
Predictor variable Standardized 
beta coefficient  
P Adjusted R
2
 
Model 1    0.654 
log retroperitoneal AdipoQ, ng/g tissue    0.650 <0.001  
log tail-head AdipoQ, ng/g tissue   0.366   0.009  
    
Model 2    0.608 
Retroperitoneal tissue mass, kg -0.564   <0.001  
log omental total AdipoQ, µg 0.515     0.001  
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Fig. 1. Representative serial dilution curve for tissue preparations of visceral (retroperitoneal) 
and subcutaneous (tail-head) AT depots, demonstrating parallelism with the standard curve. 
B/Bo = Percent of maximum binding.   
 
 
Fig. 2. Time dependent changes in serum adiponectin (AdipoQ) concentrations (µg/ml) and 
Revised Quantitative Insulin Sensitivity Check Index (RQUICKI). Different letters (a – d for 
serum AdipoQ; y and z for RQUICKI) indicate significant differences (P < 0.05; general linear 
mixed model) between the means at different time points. Data are presented as means ± S.E.M. 
In post partum period, serum AdipoQ was significantly correlated with RQUICKI (r = 0.236, P 
= 0.007). 
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Fig. 3. Tissue adiponectin (AdipoQ) concentration (ng/mg total protein and ng/g wet tissue) in 
visceral and subcutaneous adipose tissue (AT) depots in different lactation periods i.e. d 1, 42 
and 105 after parturition. Significant differences in AdipoQ concentrations within tissue are 
indicated by asterisks (*P < 0.05 and **P < 0.01; Mann-Whitney U test) for ng/mg total protein 
or different small letters (a – c, P < 0.05) for ng/g wet tissue. Capital letters within the bars 
indicate significant differences in AdipoQ concentrations between different AT depots at d 1, 42 
and 105 (A, B, C for ng/mg total protein and X, Y, Z for ng/g wet tissue; P < 0.05; Mann-
Whitney U test). Data are presented as means ± S.E.M. 
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Fig. 4. (A) Amount of adiponectin (AdipoQ, µg) in different visceral (retroperitoneal, 
mesenterial, omental) and subcutaneous (sc) adipose tissue (AT) depots in different lactation 
periods i.e. d 1, 42 and 105 after parturition. Asterisks indicate significant differences on day of 
observation (*P < 0.05, **P ≤ 0.01 and ***P ≤ 0.001; Mann-Whitney U test). Different letters 
within the bars (a, b) designate significant difference between days within depot (P < 0.05; 
Mann-Whitney U test); (B) Time dependent changes in absolute depot mass (kg) of visceral 
(mesenterial, omental and retroperitoneal) and subcutaneous (sc) (pooled for sternum, tail-head 
and withers fat) adipose tissue (AT) depots in different lactation periods i.e. d 1, 42 and 105 
after parturition. Different letters (a, b) designate significant difference between days within 
depot (P < 0.05, Mann-Whitney U test). Data are presented as means ± S.E.M. 
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Fig. 5. Portion (%) of circulating adiponectin (AdipoQ) present in visceral (vc) (pooled for 
mesenterial, omental and retroperitoneal fat depot) and subcutaneous (sc) (pooled for sternum, 
tail-head and withers fat depot) adipose tissue (AT) depots in different lactation periods i.e. d 1, 
42 and 105 after parturition. Estimated amount of AdipoQ in circulation (mg) on d 1, 42 and 
105 was 358.2 ± 51.2, 591.8 ± 48.4 and 665.5 ±72.3, respectively. Asterisks indicate significant 
differences (*P < 0.05, **P ≤ 0.01; Mann-Whitney U test). Different letters within the bars (a, 
b) designate significant difference between days within depot (P < 0.05, Mann-Whitney U test). 
Data are presented as means ± S.E.M. 
 
Fig. 6. Exemplary Western blots of AdipoQ multimeric isoforms (HMW, high molecular 
weight; MMW, middle molecular weight) under non reducing and non heat-denaturing 
conditions in adipose tissue (AT) extracts and serum at d 1 (A), d 42 (B) and d 105 (C) of 
lactation. Lane1, mesenterial AT extract; Lane 2, omental AT extract; Lane 3, retroperitoneal 
AT extract; Lane 4, wither AT extract; Lane 5, tail-head AT extract; Lane 6, sternum AT 
extract; Lane 7, serum. The band corresponds to the low molecular weight (LMW) isoform (at 
the level of approximately 70 kDa; [2]) and was not observed in tissue extract or serum at any 
time point.  
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ABSTRACT 
Adiponectin, one of the most abundant adipokines in circulation, is known for 
its role in regulation of body metabolism. The aim of this study was to evaluate the 
effects of a negative energy balance (NEB) at 2 stages of lactation (lactational NEB at 
the onset of lactation and an induced NEB by feed restriction near 100 d of lactation) on 
circulating adiponectin concentrations. We also investigated the effect of feed 
restriction on adiponectin concentrations in milk and the relationships of blood and milk 
adiponectin with selected plasma or milk variables and with measures of body 
condition. Plasma adiponectin was measured in 50 multiparous Holstein dairy cows 
throughout 3 experimental periods, i.e. period 1 = 3 wk ante partum up to 12 wk post 
partum, 2 = 3 wk of feed restriction started at around 100 days in milk with a control (n 
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= 25) and feed restricted group (50% of energy requirements; n = 25), and 3 = 
subsequent realimentation period for 8 wk. Milk adiponectin was investigated among 
twenty one multiparous cows at wk 2, wk 12 of period 1 and wk 2 of period 2. 
Adiponectin concentrations in plasma and skim milk were measured using an in-house 
ELISA specific for bovine adiponectin. Major changes in circulating adiponectin 
concentrations were observed during the periparturient period whereas energy 
deficiency during established lactation at around 100 days in milk and subsequent 
refeeding did not affect plasma adiponectin. At the second wk of feed restriction, 
adiponectin secretion via milk was reduced (mg/d; P < 0.01) and a trend for lower 
adiponectin concentrations in milk was observed (µg/mL; P = 0.087). Mean adiponectin 
concentrations in milk (0.61 ± 0.03 µg/mL) were about 52-fold lower (P < 0.001) than 
the mean plasma adiponectin concentrations (32.1 ± 1.0 µg/mL). The share of 
adiponectin from blood that is secreted via milk per day was estimated as 2.7%. In view 
of the nearly similar extent of NEB in both periods of energy deficiency, decreasing 
adiponectin concentrations seem important for accomplishing the adaptation to the 
rapidly increasing metabolic rates in early lactation whereas the lipolytic reaction 
towards feed restriction-induced NEB during established lactation seems to occur 
largely independent of changes in circulating adiponectin.  
 
Key words: adiponectin, milk, energy deficiency, dairy cow  
 
Short Communication 
With the onset of lactation in high producing dairy cows, milk synthesis leads to 
an approximately 4-fold increase in total energy requirements compared to pregnant and 
non lactating state (Block et al., 2001), which is often accompanied by insufficient 
voluntary feed intake. The period of negative energy balance (NEB) is associated with 
changes of several metabolic key hormones such as growth hormone (GH), IGF-1 and 
the responsiveness of peripheral tissues for these hormones (Rhoads et al., 2007). The 
period of energy demand such as early lactation in dairy cattle is characterized by an 
increase in lipolysis and a decrease in lipogenesis (McNamara and Hillers, 1986). 
During lipolysis, fatty acids in the form of non-esterified fatty acids (NEFA) are 
released from adipose tissue (AT) and serve as a major energy substrate for body 
tissues. 
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Adipose tissue is not only an energy storage organ, but also synthesizes and 
secretes a wide range of metabolically active hormones, proteins and other bioactive 
molecules, collectively termed as adipokines. Changes in metabolic activities of AT 
during the period of NEB may affect the expression of adipokines and vice versa e.g. 
energy deficiency in periparturient cows reduce leptin gene expression and its plasma 
concentrations (Block et al., 2001).  
Produced mainly by AT, adiponectin one of the most abundant adipokines in 
circulation is known to be involved in regulation of glucose and fatty acid metabolism 
(Yamauchi et al., 2002). Studies about the concentration of adiponectin in bovine body 
fluids have been impeded by the lack of inexpensive, straightforward and reliable assays 
for bovine adiponectin. Using semi quantitative Western immune blotting the 
circulating adiponectin concentrations in dairy cows were recently characterized and 
were shown to be lowest during the periparturient period (Giesy et al., 2012, Mielenz et 
al., 2013). Using an ELISA system we recently developed specifically for bovine 
adiponectin, this time course was confirmed (Mielenz et al., 2013) and supports that 
adiponectin participates in coordinating the metabolic changes during the period of 
NEB in early lactation. 
In rats, short-term (48 h) dietary fasting (no feed) decreased and refeeding 
increased adiponectin gene expression in perirenal AT (Zhang et al., 2002) as well as in 
subcutaneous and epididymal AT (Bertile and Raclot, 2004). However, the influence of 
feed restriction or complete feed deprivation on circulating adiponectin remains obscure 
since previous rodent studies have reported contradictory findings with unchanged 
(after 48 h of fasting) (Zhang et al., 2002), decreased (after 8 h of fasting and remain 
constant thereafter until 48 h)  (Gui et al., 2003), or increased (after feed restriction of 
60% of the baseline intake) (Combs et al., 2003) adiponectin blood concentrations.  
Changes in milk concentration of hormones and metabolites might reflect 
variations in their blood concentrations. Earlier reports suggest that the induced NEB by 
feed restriction in dairy cows alters milk yield and its composition such as fat and 
protein percentage (Gross et al., 2011a) or BHBA and citrate concentration (Nielsen et 
al., 2003). The objectives of the present study were to investigate the effect of 
lactational versus feed restriction induced NEB on plasma and milk adiponectin 
concentrations and their relationship with circulating concentrations of metabolic 
hormones such as leptin, GH, IGF-1, insulin, triiodothyronine, thyroxin; variables 
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linked to the fat metabolism such as NEFA, BHBA, total cholesterol, triglyceride and 
other variables such as urea, Revised Quantitative Insulin Sensitivity Check Index 
(RQUICKI), DMI, BW, BCS, back fat thickness (BFT), longissimus dorsi muscle 
diameter (MD) and energy balance.  
The animal trial was conducted at the Agricultural Experimental Unit Hirschau 
of the Technical University Munich, Germany, and was approved by the state 
department for animal welfare affairs. The animal experiment and feeding regimen was 
described in detail previously (Gross et al., 2011a). Briefly, the study included 50 
multiparous Holstein dairy cows (3.2 ± 0.2 lactations, mean ± SEM) from wk 3 ante 
partum (a.p.) to approximately wk 26 post partum (p.p.). Period 1 was from wk 3 a.p. 
till wk 12 p.p., where all animals were treated as one group. The restriction phase 
(period 2) started at 98 ± 7 DIM and lasted for 3 wk. In this period animals were 
allocated equally to either a control group (C, n = 25) or a restriction group (R, n = 25). 
The wk before the start of the feed restriction was considered as wk 0, when all animals 
were treated as one group. Calculations for dietary requirement of energy and protein 
followed the recommendations of the Society of Nutrition Physiology (GfE, 2001). At 
the start of period 2, an energy deficiency of approximately 50% of cow’s requirements 
was induced by feeding R cows a diet with a lower energy content (6.24 vs 6.53 MJ of 
NEL/kg of DM) compared to the C cows and decreased amount of concentrate (0.4 kg 
DM/d; whereas C cows received concentrate according to the individual requirements 
for milk production). After 3 wk of feed restriction, period 3 (8 wk duration) started 
during which R cows were (re)fed to the level of the C cows (realimentation period).  
Blood samples (n = 50) were collected weekly via jugular vein puncture in 
K3EDTA-coated (18 mL) evacuated blood collection tubes (Greiner, Frickenhausen, 
Germany). Plasma samples were obtained by centrifugation (2,000 × g, 15 min) and 
stored at -20 °C until analyzed. Cows were milked twice daily at 0500 and 1500 h and 
daily milk yield was recorded electronically. Milk samples (n = 21) at 2 consecutive 
milkings were collected at wk 2, wk 12 (period 1) and wk 2 of the energy restriction 
period (period 2) for adiponectin analysis. Milk samples were vortexed properly to 
ensure sample uniformity before skimmed by centrifugation (3,000 × g, 30 min, 4 °C). 
Skim milk was harvested between the supernatant (fat layer) and the pellet (debris and 
cells) and stored at -20 °C until analysis. 
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Plasma and skim milk samples were analyzed for adiponectin using an in-house 
competitive ELISA as described in detail earlier (Mielenz et al., 2013). Before 
measurement of milk adiponectin, assay accuracy was confirmed by linearity and 
parallelism of diluted milk samples. The measuring range of the assay was 0.07-1.00 
ng/mL and the limit of detection was 0.03 ng/mL. The intra- and inter-assay coefficients 
of variations for skim milk were 5% and 12%, respectively.  
Enzymatic kits from bioMérieux SA, Geneva, Switzerland were used for 
measurements of total cholesterol (no. 61219), triglycerides (no. 61236) and urea (no. 
61974) in plasma. The profiles of other variables such as NEFA, BHBA, DMI, BW, 
EB, BCS, BFT, MD, milk yield (Gross et al., 2011a); and RQUICKI, insulin, IGF-1, 
GH, leptin, triiodothyronine, thyroxin (Gross et al., 2011b) have been published 
elsewhere. In this paper the values were used to calculate the potential association with 
plasma and milk adiponectin concentrations.  
Adiponectin secretion (mg/d) via milk was calculated by multiplying the milk 
adiponectin concentration (mg/L) with the milk yield (L/d). In addition, assuming that 
all milk adiponectin is derived from the circulation, the following calculations were 
done to estimate the portion of circulating adiponectin (%) secreted via milk per day: 
 Total blood volume of a cow (mL) = Body weight (kg) × 57 (Hansard et al., 
1953)  
 Plasma volume (mL) = Blood volume (mL) × 0.658 (Jones et al., 1956)  
 Amount of adiponectin present in circulation (mg) = Plasma adiponectin 
concentration (mg/mL) × plasma volume (mL)  
 Amount of adiponectin secreted via milk (mg) = Milk adiponectin 
concentration (mg/L) × milk yield (L)  
Portion of blood adiponectin secreted via milk (%)  
Amount of adiponectin secreted via milk (mg) 
                      =           × 100  
Amount of adiponectin present in circulation (mg) 
 
All statistical analyses were performed using SPSS (version 19.0, SPSS Inc., 
Chicago, IL). Data were tested for normal distribution using the Shapiro-Wilk test and 
homogeneity of variances was tested using Levene’s test. One-way repeated measures 
ANOVA followed by Bonferroni post hoc test was conducted for multiple comparisons 
of plasma adiponectin concentrations at different time points during period 1. During 
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period 2 and 3, plasma adiponectin concentrations between C and R groups were 
compared with the linear mixed model procedure followed by Bonferroni correction. 
The model included individual animal as a repeated subject, and wk, treatment and their 
interaction as fixed effects. Milk adiponectin concentrations, adiponectin secretion and 
portion of plasma adiponectin secreted per d in period 1 and period 2 were compared by 
student’s t-test. Pearson correlation coefficient was calculated for statistical analysis of 
relationship among variables. All data are presented as means ± SEM, significance was 
declared for P-values < 0.05 and a trend was noted when P ≤ 0.10. 
Time dependent changes in plasma adiponectin concentrations during different 
experimental periods are shown in Figure 1. Plasma adiponectin decreased from wk 3 
a.p. and reached lowest concentrations at the time of parturition; thereafter the 
concentration increased gradually and approached a.p. values (3 wk a.p.) within 3 wk of 
lactation. The time and treatment dependent changes in milk adiponectin concentration 
and daily milk adiponectin secretion are presented in Figure 2.  
When normalized to the amount of milk protein content, the mean milk 
adiponectin concentration was 18.5 ± 0.9 ng/mg milk protein. Irrespective of time and 
treatment, milk adiponectin represented about 0.002% of total milk protein. The mean 
adiponectin concentration in milk (0.6 ± 0.03 µg/mL) was about 52-fold lower than the 
mean plasma adiponectin concentration (32.1 ± 1.0 µg/mL). Considering all time points 
(wk 2, wk 12 of period 1 and wk 2 of period 2), 2.7% of circulating adiponectin were 
secreted through milk per day. The portions of circulating adiponectin secreted through 
milk in different periods are presented in Figure 3. Neither the plasma nor the milk 
adiponectin concentration was correlated with the milk yield. No significant association 
of plasma and milk adiponectin with plasma leptin and GH was observed. The 
coefficients of correlation between plasma and milk adiponectin concentrations and 
adiponectin secretion with plasma, milk and other variables are presented in Table 1 and 
Table 2.  
The transition from late gestation to lactation is a period of comprehensive 
physiological and metabolic adaptations to accomplish the nutrient demand of the 
mammary gland for milk production. Adiponectin is known to be involved in regulating 
glucose and fatty acid metabolism (Yamauchi et al., 2002), therefore, adiponectin 
concentrations are likely to change during this period of NEB. We observed decreased 
plasma adiponectin concentrations from 3 wk a.p. until parturition and subsequently 
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gradually increased concentrations rebounding over the next 4 wk of lactation. Similar 
characteristic patterns of peripartal changes of circulating adiponectin were recently 
characterized in dairy cows using semiquantitative Western immunoblotting (Giesy et 
al., 2012, Mielenz et al., 2013) and the ELISA used herein (Mielenz et al., 2013). 
Ruminants largely depend on gluconeogenesis for their glucose requirements, therefore, 
efficient gluconeogenesis in dairy cows is the major pathway for maintaining adequate 
glucose supply for the mammary gland (Reynolds et al., 1988). Adiponectin increases 
glucose uptake and lactate production in skeletal muscle and reduces the expression of 
molecules involved in gluconeogenesis in liver (Yamauchi et al., 2002), thus, 
suppresses hepatic glucose production (Zhou et al., 2005). Furthermore, adiponectin is 
known to improve insulin sensitivity (Yamauchi et al., 2001). Together with decreasing 
insulin sensitivity in peripheral tissue, decreasing adiponectin concentrations may 
support partitioning of glucose towards mammary gland. Moreover, decreasing 
adiponectin concentrations might increase hepatic gluconeogenesis to improve glucose 
supply to the mammary gland for milk production. The precise functional importance of 
the periparturient reduction of circulating adiponectin in dairy cows remains to be 
characterized. 
We did not observe significant effects of feed restriction and subsequent 
realimentation on plasma adiponectin concentrations even though the extent of NEB 
was lower than that observed at the time of initiation of lactation (Gross et al., 2011a). 
The unchanged plasma adiponectin in R cows compared to the C cows indicates that its 
circulating concentration is not affected by energy balance. The finding of unchanged 
adiponectin concentrations during feed restriction agrees with results of energy 
restriction (4 d) study in human (Imbeault et al., 2004) or total feed deprivation studies 
in rodents (48 h fasting) (Combs et al., 2003, Kmiec et al., 2005) and humans (48-72 h 
fasting) (Gavrila et al., 2003, Merl et al., 2005). However, another report suggests that 
adiponectin concentration is decreased in mice after 8 h of fasting (Gui et al., 2003). 
The discrepancy in these results might be due to age, physiological state, extent and 
duration of fasting and/or species differences.  
From wk 2 to wk 12 p.p., milk adiponectin concentrations and adiponectin 
secretion declined 2-fold and 1.8-fold, respectively. In contrast, earlier human studies 
reported either unchanged (Bronsky et al., 2011) or increased milk adiponectin 
concentrations during the first 180 days after birth (Ozarda et al., 2012). The milk yield 
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of the animals in the present study was similar at wk 2 and wk 12 (Gross et al., 2011a) 
therefore, the observed decline in adiponectin secretion in period 1 resulted from 
decreased milk adiponectin concentration. In period 2, we observed a trend towards 
reduced adiponectin concentrations in milk in the R group compared to the C group. In 
addition, milk yield was significantly reduced in the R group during this period (Gross 
et al., 2011a) therefore, the reduction of both milk adiponectin concentration and milk 
yield lead to decreased adiponectin secretion in R cows.  
Rate of synthesis and clearance determine the blood concentration of hormones 
and metabolites. Adiponectin secretion rate from human adipocytes play only a minor 
role in variation of its blood concentration (Hoffstedt et al., 2004). Moreover, liver 
mediated clearance rate of adiponectin in mice is relatively stable (half-life ~ 75 min) 
and did not affect by 24 h fasting (Halberg et al., 2009). Therefore, decline in 
adiponectin secretion through milk during the period of feed restriction might provide 
an additional mechanism to prevent significant fall in its plasma concentration during 
this period. Compared to the concentration of leptin in milk that are around 6 ng/mL 
(Pinotti and Rosi, 2006), the mean milk adiponectin concentration observed herein 
(616.4 ± 32.6 ng/mL) were about 100-fold higher, suggesting that similar to the blood 
concentrations, adiponectin in milk is present in much higher concentration then other 
adipokines. 
In humans and in animals such as horses, adiponectin mRNA expression and 
serum concentrations are decreased with an increased portion of body fat (Kearns et al., 
2006, Kern et al., 2003). In dairy cows, an increase in fat mass could be expected with 
improvement in the body condition measures such as BW, BCS, and BFT. This might 
explain the observed negative correlations of plasma adiponectin with measures of body 
condition (BW, BCS, BFT, MD) in the present study. The positive correlation between 
plasma adiponectin and insulin concentrations might indicate that the adiponectin 
secretion by adipocytes is stimulated by insulin (Blümer et al., 2008). Moreover, 
inhibitory effects of adiponectin on lipolysis (Qiao et al., 2011) and/or stimulatory 
effects on fatty acid oxidation in liver and muscles (Yamauchi et al., 2002) could 
explain the inverse association between adiponectin and NEFA observed in the current 
study. Adiponectin might increase DMI via stimulating the hypothalamic AMP-
activated protein kinase as reported in mice (Kubota et al., 2007). However, the precise 
role of adiponectin in regulation of feed intake in dairy cows warrants further 
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investigation. The observation that plasma adiponectin and leptin were not correlated in 
the present study supports the notion that they independently regulate biological 
functions in the body such as insulin sensitivity (Koebnick et al., 2008).  
To summarize, our data showed that the most prominent changes in plasma 
adiponectin occur around parturition. Feed restriction and subsequent realimentation did 
not affect its circulating concentrations; therefore, we assume that energy balance is 
affecting plasma adiponectin only in case of the initial adaptations to the rapidly 
increasing metabolic rates in early lactation. Feed restriction resulted in reduced 
adiponectin secretion via milk and a tended to decrease milk adiponectin 
concentrations. The putative biological significance of milk adiponectin and its 
relationship with other milk hormones and metabolites still remains to be characterized.  
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Table 1. Pearson correlation coefficients between plasma adiponectin (µg/mL) and plasma, 
milk and other variables (n = 50) 
 
Period 1 = 3 wk before calving until wk 12 of lactation; Period 2 = period of energy restriction (wk 15 
until wk 17 of lactation); Period 3 = period of realimentation (wk 18 until wk 25 of lactation); Before 
calving = 3 wk before calving until calving; After calving = calving until wk 12 of lactation; Entire 
duration = 3 wk before calving until end of experiment  
C = control; R = energy restriction; RQUICKI = revised quantitative insulin sensitivity check index; TG 
= triglyceride; DMI = dry matter intake; BW = body weight; EB = energy balance; BCS = body 
condition score; BFT = back fat thickness 
#All data at wk 2, 12 of period 1 and wk 2 of period 2 (n = 21) were used for analysis 
Correlation coefficients > 0.1 with significant and trend associations are presented. †P ≤ 0.10, *P ≤ 
0.05, 
**
P ≤ 0.01, ***P ≤ 0.001  
Data have been presented earlier §Gross et al. (2011a); ‡Gross et al. (2011b) 
 
 
 
 
 
 
 
 
 
Variables 
 
Period 1  Period 2 
 
 
Period 3 
Entire 
duration  Before 
calving 
After 
calving 
Entire 
period 1 
 C Group  R Group 
 
Plasma variables            
NEFA (mmol/L)§   -0.225*** -0.148***   0.227*     -0.190*** 
BHBA (mmol/L)§  -0.315***          
Insulin (µU/mL)‡    0.219*** 0.208***   0.365***      0.226*** 
            
Milk variables#§            
Milk adiponectin 
(ng/mL) 
   -0.360*  0.542†      
Milk fat (%)    -0.290†    -0.777**   -0.283* 
Milk protein (%)    -0.366*       -0.355** 
            
Other variables             
RQUICKI‡   0.111†          
DMI (kg/d)§    0.313*** 0.351***     0.277*    0.185*** 
BW (kg)§  -0.17*  -0.185***    -0.258*   -0.152*** 
BCS§  -0.395*** -0.357*** -0.402***    -0.299**  -0.313*** -0.374*** 
BFT (mm)§  -0.149† -0.284*** -0.277***  -0.263*  -0.248*  -0.301*** -0.253*** 
EB (MJ of 
NEL/d)
§ 
   0.253***    0.208**   0.389***    
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Table 2. Pearson correlation coefficients of milk adiponectin concentration (µg/mL) and milk 
adiponectin secretion via milk (mg/d) with milk, plasma and other variables  
 
 
 
 
 
 
 
 
 
Data at wk 2, wk 12 of period 1 and wk 2 of period 2 were used for analysis (n = 21) 
Correlation coefficients > 0.1 with significant associations are presented. 
*
P ≤ 0.05, **P ≤ 
0.01, 
***
P ≤ 0.001  
RQUICKI = revised quantitative insulin sensitivity check index; BW = body weight; BCS 
= body condition score; BFT = back fat thickness; EB = energy balance 
Data have been presented earlier §Gross et al. (2011a); ‡Gross et al. (2011b) 
 
 
 
 
 
 
 
 
 
 
 
 
Variables  Milk Adiponectin   Adiponectin secretion 
Milk variables
§
    
Milk yield (kg)   0.478
***
 
Milk fat (%)  0.466
***
 0.421
***
 
Milk protein (%)   0.322
**
  
    
Plasma and other variables     
Leptin (ng/mL)
‡
  -0.399
**
 -0.282
*
 
NEFA (mmol/L)
§
  0.613
***
 0.683
***
 
BHBA (mmol/L)
§
  0.327
*
 0.404
**
 
Glucose (mmol/L)
§
  -0.493
***
 -0.470
***
 
RQUICKI
‡
  -0.431
***
 -0.462
***
 
BW (kg)
§
   0.422
***
 
BCS
§
  0.283
*
 0.397
***
 
BFT (mm)
§
   0.343
***
 
EB (MJ of NEL/d)
§
  -0.304
**
 -0.354
**
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Figure 1. Plasma adiponectin concentration (µg/mL) in cows (n = 50) during the experimental 
period 1 (from wk 3 ante partum up to wk 12 post partum), period 2 (3 wk of feed restriction, 
started at about 100 DIM), and period 3 (8 wk of realimentation). Data are given as mean ± 
SEM. Significant differences (P < 0.05) between the time points during period 1 are presented 
as lower case (one-way repeated measure ANOVA followed by Bonferroni post hoc test). ns 
indicate no significant differences (linear mixed model) between the control (n = 25) and feed-
restricted (n = 25) groups. 
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Figure 2. Skim milk adiponectin concentration (ng/mL) and adiponectin secretion via milk 
(mg/d) at wk 2 and wk 12 of period 1 (n = 21) and control (C, n = 11) and feed-restricted (R, n 
= 10) groups at wk 2 of period 2. Data are given as mean ± SEM. Significant differences are 
presented as *** P < 0.001; ** P < 0.01 and trend as † P < 0.10 (Student’s t-test). 
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Figure 3. Portion of plasma adiponectin (%) secreted via milk per d at wk 2 and wk 12 of 
period 1 (n = 21) and control (C, n = 11) and feed-restricted (R, n = 10) groups at wk 2 of period 
2. Data are given as mean ± SEM. Significant differences are presented as *** P < 0.001; * P < 
0.05 (Student’s t-test). 
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5. General discussion and future research prospectives  
 
Circulating adiponectin profile during periparturient period and lactation in dairy 
cows  
The present study was carried out to characterize circulating adiponectin concentrations 
around parturition and during almost the entire lactation (d -21 to d 252 relative to 
calving) in primiparous (PP) and multiparous (MP) cows using an in-house developed 
ELISA specific for bovine adiponectin (Mielenz et al., 2013). Most of the changes in 
circulating adiponectin were observed around calving with a characteristic pattern of 
progressive decline from d 21 pre partum, lowest concentrations at the time of calving 
and thereafter a gradual increase. In humans, the blood adiponectin concentration is 
slightly declining as pregnancy advances, reaching the lowest concentrations after 
delivery (Asai-Sato et al., 2006). The precise underlying mechanisms for the decline in 
adiponectin concentrations around parturition are not known so far. However, endocrine 
changes around parturition might affect this variation since in vitro adiponectin 
expression and secretion is suppressed by hormones associated with calving such as 
prolactin, growth hormone and glucocorticoids (Fasshauer et al., 2002, Nilsson et al., 
2005).   
 
Effect of dietary CLA supplementation on circulating adiponectin 
In the present thesis a fat supplement containing 12% each of the cis-9, trans-11 and the 
trans-10, cis-12 CLA isomers was shown to reduce the post partum circulating 
adiponectin concentrations in both PP and MP dairy cows. Decreasing (Poirier et al., 
2005) as well as increasing (Martins et al., 2010) effects of CLA on adiponectin 
expression are reported in rodents. In vivo and in vitro studies suggest that PPARγ 
ligands such as thiazolidinediones and rosiglitazone increase expression and plasma 
concentrations of adiponectin (Iwaki et al., 2003, Maeda et al., 2001, Motoshima et al., 
2002). Incubation of cells such as primary rat adipocytes, human preadipocytes or 3T3-
L1 cells with the trans-10, cis-12 CLA isomer decrease PPARγ gene expression 
(Granlund et al., 2003, Kang et al., 2003, Perez-Matute et al., 2007). Therefore, it is 
suggested that the inhibitory effect of CLA on adiponectin expression is probably 
mediated through the suppression of PPARγ (Perez-Matute et al., 2007).  
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Adiponectin concentrations in adipose tissue depots 
Our results indicate that irrespective of the anatomical site, the adiponectin 
concentration was significantly lower in all sc (tail-head, sternum and withers) and vc 
(mesenterial, omental and retroperitoneal) fat depots at the time of parturition compared 
to early lactation. This change is likely to be the determinant for the lowest adiponectin 
concentration in blood at the time of calving. Visceral AT contained higher amounts of 
adiponectin than scAT, proposing a relatively higher contribution of vcAT on blood 
adiponectin concentrations. Similarly, adiponectin expression is significantly higher in 
vcAT than in scAT in lean rats suggesting that vc fat is the predominant contributor to 
plasma adiponectin (Altomonte et al., 2003). However, retroperitoneal AT, a type of 
vcAT depot, contained the lowest concentration and lowest total amount of adiponectin 
compared to the other vc and sc fat depots in the present study. A significant reduction 
in adipocyte size during early lactation was observed only in retroperitoneal AT (Akter 
et al., 2011) and when calculated as a portion of empty body weight (%), a decline was 
observed only in this depot (von Soosten et al., 2011). Protein expression of hormone-
sensitive lipase (rate-limiting enzyme in the lipolytic pathway) and the extent of its 
phosphorylation were higher in retroperitoneal AT compared to the sc AT of dairy cows 
during early lactation (Locher et al., 2011), indicating a higher lipolytic activity in this 
depot. Based on these features of the retroperitoneal AT, it seems that in dairy cows, 
retroperitoneal AT plays an unique role and participates more actively in lipid 
mobilization compared to other fat depots.  
 
Relationship of adiponectin with insulin sensitivity  
In the present research we observed nearly similar patterns of time dependent 
periparturient changes in serum adiponectin and IS (estimated by the Revised 
Quantitative Insulin Sensitivity Check Index). In addition, a positive correlation 
between these variables during the post parturient period was observed, suggesting an in 
vivo effect of adiponectin on IS in dairy cows. Decreasing blood adiponectin 
concentrations around parturition thus might result in decreased IS of peripheral tissues 
(Yamauchi et al., 2001), decreased glucose uptake by skeletal muscles and increased 
hepatic gluconeogenesis (Yamauchi et al., 2002). Therefore, lower blood adiponectin 
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concentration around calving might improve supply of glucose to the mammary gland 
for enhanced milk production during early lactation.  
 
Negative energy balance and adiponectin concentration 
No effect of induced NEB caused by feed restriction during established lactation (about 
100 DIM) and subsequent realimentation was observed on plasma adiponectin 
concentration, even though the extent of NEB due to feed restriction (-62.7 ± 2.0 MJ of 
NEL/d) was higher compared to the immediate post partum period (-46.1 ± 3.4 MJ of 
NEL/d) (Gross et al., 2011). However, after calving blood adiponectin concentrations 
and energy balance were at their lowest values, increased gradually during early 
lactation and were positively correlated during post partum period. The differential 
effects of NEB on circulating adiponectin concentrations at the 2 stages of lactation 
show that decline in blood adiponectin concentrations around parturition in dairy cows 
are not only due to the energy deficiency, but mainly due to the specific metabolic 
regulations during this period. 
 
Future research prospectives 
Precise mechanisms that regulate changes in the circulating adiponectin around 
parturition and its physiological importance in cattle remain to be characterized. The 
putative biological significance of milk adiponectin in the growth, development and 
health status of the offspring remain to be identified. Identification of blood adiponectin 
as a diagnostic marker for the periparturient metabolic disorders may represent 
important consideration in future studies.   
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6. Summary  
The transition from late pregnancy to lactation in dairy cows is characterized by marked 
changes in energy balance, and the metabolic and endocrine status of the animal. 
Adipose tissue (AT) plays an important role in regulating metabolism and other body 
functions such as immunity and reproduction through its secretion of adipokines. 
Adipose tissue depots at different anatomical locations [subcutaneous (sc) and visceral 
(vc) AT] are distinct in their structural and functional properties; therefore, they may 
respond in divergent ways to physiological changes such as the onset of lactation. 
Adiponectin is one of the most abundant adipokines and is linked with several 
physiological functions such as insulin sensitivity, immunity and inflammation. 
Conjugated linoleic acids (CLA) might affect adiponectin expression and secretion, as 
known from cell culture and rodent studies. In dairy cows, CLA feed supplements are 
used to decrease milk fat thus potentially alleviating the output of energy with milk 
during the first weeks of lactation when voluntary feed intake is mostly not covering the 
needs for maintenance and milk production; albeit the effect on mammary lipogenesis is 
well characterized, potential effects on body fat, in particular adiponectin secretion, 
were not known. Therefore, the experiments conducted herein aimed 1) to characterize 
the adiponectin concentrations in blood and different sc and vc AT depots from dairy 
cows during different stages of lactation, 2) to test the effect of CLA supplementation 
on blood and tissue adiponectin concentrations, and 3) to evaluate the effect of 
lactational versus dietary induced negative energy balance (NEB) on blood and milk 
adiponectin concentrations. 
In  two  different CLA trials,  German Holstein  cows  were  allocated  to  either  a  
CLA group  (100  g/d  of  a  fat supplement containing 12% each of the cis-9, trans-11 
and the trans-10, cis-12 isomer) or a control group (100 g/d of a control fat in which 
CLA was substituted by stearic acid). In trial 1, both multiparous (MP, n = 22) and 
primiparous (PP, n = 11) cows received CLA (11 MP, 5 PP) or the control fat (11 MP, 6 
PP) from d 1 to d 182 of lactation; blood samples as well as biopsy samples from tail-
head scAT were collected from MP and PP cows from d -21 to d 252 relative to calving. 
In trial 2, PP cows (n = 25) were accordingly treated and AT samples from different 
locations [3 vcAT depots (omental, mesenterial, and retroperitoneal) and 3 scAT depots 
(sternum, tail-head, and withers)] and blood samples were collected at slaughter on days 
1 (n = 5), 42 (n = 10, 5 per group)  and 105 (n = 10, 5 per group)  of lactation. In a third 
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trial, the effects of NEB at 2 stages in lactation (lactational, “natural” NEB at the onset 
of lactation versus feed restriction-induced NEB in established lactation at ~ 100 d in 
milk) on circulating and milk adiponectin concentration were studied. The experiment 
included MP Holstein dairy cows (n = 50) and the entire duration was divided into 3 
periods, i.e. period 1 = 3 wk ante partum until 12 wk post partum, period 2 = 3 wk of 
feed restriction starting at around 100 days in milk with a control (n = 25) and a feed 
restricted group (70% of energy requirements; n = 25), and 3 = realimentation period for 
8 wk. Plasma adiponectin was measured at different time points throughout the 
experiment. Milk adiponectin was investigated in a subset of 21 cows at wk 2, wk 12 of 
period 1 and wk 2 of period 2. Adiponectin concentrations in samples collected in all 
experiments were measured using an in-house developed ELISA that is the first assay 
which allows for valid quantification of bovine adiponectin suitable for large sample 
series. 
We herein demonstrated that major changes in blood adiponectin concentration appear 
during the periparturient period with a gradual decline from d 21 ante partum to lowest 
levels at the time of calving and subsequent post partum gradual increase. 
Supplementation with a 1:1 mixture of cis-9, trans-10 and trans-10, cis-12 CLA caused 
a reduction in post partum circulating adiponectin in both PP and MP dairy cows. A 
carry over effect of CLA beyond the time of supplementation was limited to MP cows. 
Nearly similar patterns of periparturient changes in serum adiponectin and IS (estimated 
by the Revised Quantitative Insulin Sensitivity Check Index) were observed. This 
observation and the result of positive associations between these variables during the 
post parturient period suggest in vivo effects of adiponectin on IS in dairy cows.  
Irrespective of the anatomical site, adiponectin concentrations in all fat depots were 
lowest at the time of parturition and increased during early lactation. The decline in 
circulating adiponectin around parturition thus likely results from reduced expression of 
the adiponectin protein in all fat depots. The finding that vcAT contained more 
adiponectin than scAT suggests a relatively higher contribution of vcAT to the blood 
concentrations. However, retroperitoneal AT as one of the vc depots contained the 
lowest adiponectin concentration and also, when related to depot mass, the lowest total 
amount of adiponectin compared to the other fat depots. No effect of induced NEB due 
to feed restriction and subsequent re-feeding was observed on plasma adiponectin 
concentrations, suggesting that circulating adiponectin is not affected by energy balance 
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during established lactation near 100 d of lactation. Besides providing information 
about longitudinal changes of blood adiponectin concentrations and the effect of CLA, 
the present thesis contributes to improving the knowledge about differential expression 
of adiponectin in various AT depots and changes in blood concentrations in dairy cows. 
Moreover, the dissertation serves as a basis for further studies exploring the role of 
adiponectin in various pathophysiological conditions in cattle and, potentially also in 
other livestock species. In future, the specific mechanisms for regulating the 
periparturient changes in circulating adiponectin concentrations and its physiological 
importance remain to be elucidated.  
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7. Zusammenfassung 
Die Übergangsphase von der späten Trächtigkeit zur frühen Laktation ist bei 
Milchkühen von ausgeprägten Veränderungen der Energiebilanz sowie des 
metabolischen und endokrinen Status gekennzeichnet. Das Fettgewebe spielt durch die 
Sekretion von Adipokinen eine wichtige Rolle in der Regulation des Stoffwechsels und 
anderer Körperfunktionen wie beispielsweise Immunität und Reproduktion. 
Fettgewebsdepots unterschiedlicher anatomischer Lokalisation [subkutan (sc) und 
viszeral (vc)] verfügen über unterschiedliche strukturelle und funktionelle 
Eigenschaften. Dies könnte dazu führen, dass sie auf verschiedene Weise auf 
physiologische Veränderungen wie das Einsetzen der Laktation reagieren. Adiponektin 
ist eines der am häufigsten vorkommenden Adipokine und ist mit verschiedenen 
physiologischen Funktionen wie Insulinsensitivität, Immunität und 
Entzündungsreaktionen verbunden. Konjugierte Linolsäuren (CLA) könnten, wie 
bereits aus Zellkulturstudien und Studien mit Nagetieren bekannt, die 
Adiponektinexpression beeinflussen. Bei Milchkühen werden CLA-Supplemente zur 
Senkung des Milchfettgehaltes verwendet. Dies dient der Verringerung des 
Energieverlusts über die Milch in den ersten Wochen der Laktation, während derer die 
Futteraufnahme meist nicht ausreicht, um den Energiebedarf für die Grunderhaltung 
und die Milchproduktion zu decken. Obgleich die CLA-Effekte auf die Lipogenese der 
Milchdrüse bereits gründlich aufgezeigt wurden, sind mögliche Einflüsse auf das 
Körperfett, insbesondere auf die Adiponektinsekretion noch unbekannt. Demzufolge 
zielen die hier durchgeführten Experimente darauf ab, 1) die 
Adiponektinkonzentrationen in Blut und verschiedenen sc und vc Fettdepots von 
Milchkühen in unterschiedlichen Laktationsstadien zu charakterisieren, 2) die Effekte 
einer CLA-Supplementation auf die Adiponektinkonzentration in Serum und Milch zu 
testen und  3) die Effekte einer laktationsbedingten sowie einer ernährungsinduzierten 
negativen Energiebilanz (NEB) auf Blut- und Milchadiponektinkonzentrationen zu 
beurteilen. 
In zwei Versuchen wurden Holstein Kühe in eine CLA-Gruppe (100 g Fettsupplement 
pro Tag mit je 10% cis-9, trans-11 und trans-10, cis-12 Isomer) oder eine 
Kontrollgruppe (100 g Fettsupplement pro Tag, Ersatz der CLA durch Stearinsäure) 
eingeteilt. In Versuch 1 erhielten sowohl multipare (MP, n = 22), als auch primipare 
(PP, n = 22) Kühe von Tag 1 bis Tag 182 der Laktation entweder CLA (11 MP, 5 PP) 
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oder das Kontrollfett (1 MP, 6 PP). Blutproben sowie Biopsien subkutanen Fettgewebes 
vom Schwanzansatz wurden von allen Kühen im Zeitraum von Tag -21 bis 252 relativ 
zur Kalbung entnommen. In Versuch 2 erfolgte eine entsprechende Fütterung von 25 PP 
Kühen und nach den Schlachtungen an Tag 1 (n = 5) , 42 und 105 (jeweils 5 Tiere pro 
Gruppe) der Laktation wurden Proben unterschiedlicher Fettdepots [3 vc Depots 
(omental, mesenterisch und retroperitoneal) und 3 sc Depots (Schwanzansatz, Widerrist 
und Sternum)], sowie Blutproben entnommen. In einem dritten Versuch wurden die 
Effekte einer NEB in zwei Stadien der Laktation (die natürliche NEB zu Beginn der 
Lakation sowie eine durch eine restriktive Fütterung hervorgerufene NEB um Tag 100 
während der Laktation) auf die zirkulierenden Adiponektinkonzentrationen sowie die 
Konzentrationen in der Milch untersucht. Der Versuch umfasste 50 Holstein Kühe und 
der gesamte Versuchszeitraum wurde in 3 Perioden eingeteilt: Periode 1 von drei 
Wochen ante partum bis zwölf Wochen post partum, Periode 2 mit drei Wochen 
restriktiver Fütterung begann an Tag 100 der Laktation mit einer Kontrollgruppe (n = 
25) und einer Restriktionsgruppe (70 % des Energiebedarfs; n = 25), gefolgt von 
Periode 3, einer Realimentationsphase über einen Zeitraum von acht Wochen. Die 
Bestimmung der Plasmaadiponektinkonzentration erfolgte an verschiedenen 
Zeitpunkten während des Versuchs. Die Messung der Adiponektinkonzentrationen in 
den Proben aller Versuche erfolgte mit einem hauseigenen ELISA, der als erster Assay 
eine valide Quantifizierung von bovinem Adiponektin in einem umfangreichen 
Probenset ermöglicht.  
Wir konnten aufzeigen, dass die wesentlichsten Veränderungen der Blutadiponektin-
konzentration während der peripartalen Phase auftreten, mit einer sukzessiven 
Verringerung ausgehend von Tag 21 ante partum hin zu einem Tiefstwert zum 
Zeitpunkt der Kalbung und einem anschließenden graduellen Anstieg post partum. Die 
Supplementation mit einer 1:1 Mischung von cis-9, trans-10 und trans-10, cis-12 CLA 
führte zu einer Verringerung des nachgeburtlich zirkulierenden Adiponektins sowohl in 
PP als auch in MP Kühen. Ein carry-over Effekt des CLA über den 
Supplementationszeitraum hinaus beschränkte sich auf die MP Kühe. Es wurden 
annähernd dieselben Muster der peripartalen Veränderungen von Serumadiponektin und 
IS (geschätzt anhand des bereinigten Quantitativen Insulin Sensitivitäts Check Index) 
ermittelt. Diese Beobachtung sowie das Ergebnis der positiven Assoziation der 
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Variablen während der postpartalen Periode lässt in vivo Effekte von Adiponektin auf 
die IS von Milchkühen vermuten. 
Unabhängig von der anatomischen Lokalisation zeigten alle Fettgewebsdepots die 
geringsten Adiponektinkonzentrationen zum Zeitpunkt der Kalbung, gefolgt von einem 
Anstieg während der frühen Laktation. Die Verringerung der zirkulierenden 
Adiponektinkonzentration um den Geburtszeitpunkt resultiert daher wahrscheinlich aus 
der reduzierten Proteinexpression in allen Fettdepots. Der höhere Adiponektingehalt im 
vc Fettgewebe deutet darauf hin, dass dieses Gewebe einen vergleichsweise höheren 
Beitrag zu den Blutkonzentrationen leistet als das sc Gewebe. Das retroperitoneale 
Fettgewebe als eines der viszeralen Depots enthielt aber die geringste 
Adiponektinkonzentration, sowie die geringste Gesamtadiponektinmenge bezogen auf 
die Depotmasse. Die durch eine restriktive Fütterung hervorgerufene NEB sowie die 
anschließende Realimentation hatten keinen Einfluss auf die 
Plasmadiponektinkonzentrationen im Zeitraum um Tag 100 der Laktation. Dies lässt 
vermuten, dass die zirkulierenden Adiponektinkonzentrationen während der Laktation 
keiner Beeinflussung durch die Energiebilanz unterliegen. Neben der Bereitstellung von 
Informationen über die longitudinalen Veränderungen der Adiponektinkonzentration im 
Blut und der Effekte von CLA, trägt die vorliegende Arbeit zu einem verbesserten 
Wissen über die unterschiedliche Adiponektinexpression in verschiedenen Fettgeweben 
sowie über Veränderungen der Blutadiponektinkonzentrationen bei. Darüber hinaus 
dient diese Dissertation als Grundlage für zukünftige Studien, die die Rolle von 
Adiponektin in unterschiedlichen pathophysiologischen Zuständen beim Rind oder 
anderen Spezies untersuchen. Die spezifischen Regulationsmechanismen der 
peripartalen Veränderungen der zirkulierenden Adiponektinkonzentrationen sowie 
deren physiologische Bedeutung bleiben weiterhin zu klären. 
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9. Appendixes  
Appendix A: Validation of in-house developed ELISA for bovine adiponectin 
 
 Criterion  Validation approach 
   
Intra-assay 
(reproducibility) and 
inter-assay (precision) 
coefficients of variation 
 Determined by repeated measurements (n = 7) of 2 different 
serum samples at 2 different dilutions (n = 4) within single 
assay and in different assays (n = 7). The mean intra- and inter-
assay coefficients of variation were 7% and 11%, respectively. 
   
Spiking recovery  Assessed by calculate the ratio of expected vs measured 
adiponectin concentrations. Two different serum samples with 
differing adiponectin concentrations (10.2 and 28.8 µg/mL) 
were mixed at 11 different ratios and were measured. The 
mean recovery was 112% ± 8.23%. In addition, the mean 
recovery of 3 different concentrations of purified adiponectin 
spiked into a serum sample in 4 different dilutions was 119% ± 
8.02%. 
   
Accuracy  Measured by demonstrating linearity and parallelism of serial 
sample dilutions and the standard curve. Dilutional linearity 
was also tested for various other bovine samples such as saliva, 
urine, follicular fluid, seminal fluid, preparations from 
different scAT and vcAT depots, cell culture supernatant of 
differentiated bovine preadipocytes and of mouse 3T3-L1 
cells, bovine whole milk, skim milk and milk serum as well as 
blood serum from different species such as sheep, goat, camel, 
mouse, pig, horse, roe deer, human, chicken, and goose. 
Dilution linearity was not observed in samples from species 
other than cattle. 
   
Specificity  Determined by testing the cross-reactivity with bovine albumin 
(Roth), calf skin collagen (Sigma-Aldrich), and the structurally 
homologous human complement factor C1q (GenWay Biotech, 
San Diego, CA, USA). Negligible cross-reactivity (i.e. 
<0.0001%) was observed for all 3 proteins. 
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Sample stability  Similar concentrations were observed in bovine serum samples 
after freeze/thaw cycles (12 times, -20 
o
C, CV < 15%), thus 
suggesting no effect of repeated freeze/thaw cycles on 
adiponectin measurements. 
   
Sensitivity or limit of 
detection 
 Defined by the least detectable dose i.e. the lowest 
concentration of adiponectin that could be distinguished from a 
zero blank by replicated determination (n = 10) (mean value + 
3 SDs). Sensitivity of the assay was 0.03 ng/mL. 
   
Measuring range  Estimated as the concentration range in which the standard 
curve was approximately linear. Measuring range for the assay 
was 0.07 – 1.0 ng/mL. 
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Appendix B: Steps followed in the ELISA for bovine adiponectin 
 
Note: composition of buffers and solution used in ELISA is given in appendix C.  
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Appendix C: Chemicals, buffers and solutions used in the ELISA for bovine adiponectin  
 
* Ultrapure water was used for preparing all buffers and solutions.   
# For preparing working washing solution: 10 mL of washing buffer/ L ultrapure water 
 
 
Chemicals, buffers and 
solutions* 
Composition Firm 
Protease inhibitor 
Complete
TM
 
1 tablet in 2 mL H2O  
 
Roche 
   
Coating buffer (pH 9.6) 50 mM NaHCO3 Roth  
 200 µL/L Protease inhibitor  
 20 mL/L Proclin 150
® 
     Supelco 
   
Casein solution (pH 7.2) 0.05 M NaOH   Applichem 
 1.5 mM EDTA (Disodium salt dihydrate)   Roth 
 2.5% Casein   Sigma 
 200 µL/L Protease inhibitor   
 20 mL/L Proclin 150
®
   
   
Assay buffer (pH 7.3) 0.12 M NaCl   Roth 
 0.02 M Na2HPO4 AppliChem 
 0.01 M EDTA   Roth 
 0.005% Chlorhexidine   Sigma 
 0.1% Gelatine (Gelatine Hydrolysate)   Sigma 
 0.05% Tween
®
20    AppliChem 
 0.002% Phenol red   Sigma 
 200 µL/L Protease inhibitor  
 20 mL/L Proclin 150
®
  
   
Substrate buffer (pH 4.05)  0.05 M Citric acid   AppliChem 
 0.055 M Na2HPO4  
 0.05% Urea peroxide   Sigma 
 20 mL/L Proclin 150
®
  
   
TMB-solution 12.5 mg TMB (3, 3, 5, 5-Tetramethylbenzidine)   AppliChem 
 1 mL DMSO (Dimethyl sulfoxide)   AppliChem 
   
Substrate solution 18 mL substrate buffer   
 360 µL TMB-solution  
   
Stop solution 1 M Oxalic acid  Roth 
   
Washing buffer
 
(10-fold; 
pH 6.8)
# 
  
1.36 M NaCl  
 
 
 81 mM Na2HPO4  
 27 mM KCl    Roth 
 15 mM KH2PO4 Roth 
 20 mL/L Proclin 150
®
  
 55 g/L Tween
®
20   
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